⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9411280 | 1.00 | — | — | |
| SCHEMBL542409 | 0.96 | — | — | |
| SCHEMBL451573 | 0.89 | — | — | |
| SCHEMBL27938552 | 0.73 | — | — | |
| SCHEMBL4141244 | 0.71 | — | — | |
| SCHEMBL2106124 | 0.69 | KCNH2 (0.39) | — | |
| SCHEMBL209150 | 0.69 | EPHX1 (0.35) | — | |
| SCHEMBL2709123 | 0.67 | — | — | |
| SCHEMBL10011097 | 0.64 | KCNH2 (0.32) | — | |
| SCHEMBL7082443 | 0.64 | EPHX1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 950 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113549049-B | Polysubstituted thienocyclopentanone derivative and synthetic method thereof | 中国科学院大连化学物理研究所 | 2022-04-15 | — | — | CN | claimed |
| CN-113549049-A | Polysubstituted thienocyclopentanone derivative and synthetic method thereof | 中国科学院大连化学物理研究所 | 2021-10-26 | — | — | CN | claimed |
| US-10226452-B2 | Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-03-12 | — | — | US | claimed |
| US-20170182010-A1 | BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2017-06-29 | — | — | US | claimed |
| CN-103172657-B | Containing the functionalized cage modle polyhedral polysilsesquioxane and preparation method thereof of alkynyl | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2016-03-30 | — | — | CN | claimed |
| WO-2015173168-A1 | BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2015-11-19 | — | — | WO | claimed |
| CN-103172657-A | Alkynyl-containing functionalized cage-type polyhedral polysilsesquioxane and preparation method thereof | UNIV BEIJING CHEMICAL | 2013-06-26 | — | — | CN | claimed |
| EP-1178088-B1 | Clear coating composition, method of forming a coating film and multilayer coating film | NISSAN MOTOR (JP) | 2006-10-11 | — | — | EP | claimed |
| EP-0137390-B1 | SUBSTITUTED BETA-CARBOLINES, PROCESS FOR THEIR PREPARATION AND THEIR USE AS MEDICAMENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1990-08-16 | — | — | EP | claimed |
| EP-0111711-B1 | HETEROCYCLICALLY SUBSTITUTED HYDROXYALKYL-AZOLYL DERIVATIVES | BAYER AG (DE) | 1987-03-18 | — | — | EP | claimed |
| US-4639462-A | Heterocyclo-hydroxyalkyl-azolyl derivatives and use as fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 1987-01-27 | — | — | US | claimed |
| US-4632932-A | TRIAZOLYL-DIOXOLANYL OR DIOXANYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-30 | — | — | US | claimed |
| EP-0111146-B1 | ANTI-MYCOTIC HYDROXYALKYL-AZOLYL DERIVATIVES | BAYER AG (DE) | 1986-12-30 | — | — | EP | claimed |
| US-4623649-A | PSYCHOPHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-11-18 | — | — | US | claimed |
| EP-0193642-A2 | Heterocyclically substituted hydroxyalkyl-azolyl derivatives | BAYER AG (DE) | 1986-09-10 | — | — | EP | claimed |
| EP-0111711-A2 | Heterocyclically substituted hydroxyalkyl-azolyl derivatives | BAYER AG (DE) | 1984-06-27 | — | — | EP | claimed |
| EP-0111146-A2 | Anti-mycotic hydroxyalkyl-azolyl derivatives | BAYER AG (DE) | 1984-06-20 | — | — | EP | claimed |
| US-4436661-A | INTERMEDIATES FOR PENICILLIN ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1984-03-13 | — | — | US | claimed |
| EP-0026742-A1 | Diazaphospholanes and diazaphosphorinanes, their use as protecting agents against light and material stabilized therewith | CIBA-GEIGY AG (CH) | 1981-04-08 | — | — | EP | claimed |
| JP-58133874-A | — | — | None | — | — | JP | disclosed |
| JP-57202369-A | — | — | None | — | — | JP | disclosed |
| US-20240115553-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | AZEVAN PHARMACEUTICALS, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| US-20240117117-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2024-04-11 | — | — | US | disclosed |
| WO-2024064209-A1 | COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIUM INFECTIONS | DATA2DISCOVERY, INC. (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024039864-A1 | PROTEIN:PROTEIN INTERACTION INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2024-02-22 | — | — | WO | disclosed |
| EP-4324882-A2 | BINDERS | Knauf Insulation SPRL (BE) | 2024-02-21 | — | — | EP | disclosed |
| US-20240034918-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION SPRL (BE) | 2024-02-01 | — | — | US | disclosed |
| EP-3146010-B1 | BINDERS | KNAUF INSULATION INC (US) | 2023-12-13 | — | — | EP | disclosed |
| US-11814481-B2 | Carbohydrate polyamine binders and materials made therewith | KNAUF INSULATION, INC. (US) | 2023-11-14 | — | — | US | disclosed |
| WO-2023215238-A1 | PREPARATION AND USES OF 7-AZAINDENOISOQUINOLINES | PURDUE RESEARCH FOUNDATION (US) | 2023-11-09 | — | — | WO | disclosed |
| EP-4245762-A2 | BINDERS AND ASSOCIATED PRODUCTS | Knauf Insulation SPRL (BE) | 2023-09-20 | — | — | EP | disclosed |
| EP-3728444-B1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION SPRL (BE) | 2023-08-23 | — | — | EP | disclosed |
| US-11725124-B2 | Binders and associated products | KNAUF INSULATION, INC. (US) | 2023-08-15 | — | — | US | disclosed |
| US-20230203080-A1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2023-06-29 | — | — | US | disclosed |
| CN-116327950-A | Use of a composition for the treatment of neuropsychiatric symptoms of neurodegenerative diseases | 阿泽范药品公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116139282-A | Compositions and methods for treating neurodegenerative diseases | 阿泽范药品公司 | 2023-05-23 | — | — | CN | disclosed |
| US-20230123729-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | AZEVAN PHARMACEUTICALS INC (US) | 2023-04-20 | — | — | US | disclosed |
| US-11629258-B2 | Energy curable inkjet inks for the production of layered composites | SUN CHEMICAL CORPORATION (US) | 2023-04-18 | — | — | US | disclosed |
| US-11628160-B2 | Compositions and methods for treating brain injury | AZEVAN PHARMACEUTICALS, INC. (US) | 2023-04-18 | — | — | US | disclosed |
| CN-107404876-B | Anticancer therapeutic agent | 雷尔有限责任公司 | 2023-04-14 | — | — | CN | disclosed |
| CN-106459021-B | Compositions and methods for treating neurodegenerative diseases | 阿泽范药品公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-115943067-A | Laminated manufacturing using soft gel forming materials | 斯特拉塔西斯公司 | 2023-04-07 | — | — | CN | disclosed |
| US-20230056560-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION SPRL (BE) | 2023-02-23 | — | — | US | disclosed |
| US-20220389286-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION, INC. (US) | 2022-12-08 | — | — | US | disclosed |
| US-11453807-B2 | Binders and associated products | KNAUF INSULATION, INC. (US) | 2022-09-27 | — | — | US | disclosed |
| US-11384203-B2 | Binder | KNAUF INSULATION, INC. (US) | 2022-07-12 | — | — | US | disclosed |
| US-20220175875-A1 | METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES | ENDOCYTE INC (US) | 2022-06-09 | — | — | US | disclosed |
| US-11332577-B2 | Binders | KNAUF INSULATION SPRL (BE) | 2022-05-17 | — | — | US | disclosed |
| US-11319306-B2 | Compositions and methods for treating neurodegenerative diseases | AZEVAN PHARMACEUTICALS, INC. (US) | 2022-05-03 | — | — | US | disclosed |
| US-20220125958-A1 | COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | PURDUE RESEARCH FOUNDATION | 2022-04-28 | — | — | US | disclosed |
| CN-113549049-B | Polysubstituted thienocyclopentanone derivative and synthetic method thereof | 中国科学院大连化学物理研究所 | 2022-04-15 | — | — | CN | disclosed |
| EP-3153023-B1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | TAKEDA PHARMACEUTICALS CO (JP) | 2022-03-16 | — | — | EP | disclosed |
| CN-110218456-B | Cyclohexyl LED packaging material and preparation method thereof | 矽时代材料科技股份有限公司 | 2022-01-18 | — | — | CN | disclosed |
| US-20220010067-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2022-01-13 | — | — | US | disclosed |
| US-20220002487-A9 | BINDER | KNAUF INSULATION SPRL (BE) | 2022-01-06 | — | — | US | disclosed |
| US-20210403645-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2021-12-30 | — | — | US | disclosed |
| EP-3922655-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | Knauf Insulation (BE) | 2021-12-15 | — | — | EP | disclosed |
| EP-3266841-B1 | COMPOSITION FOR POWDER COATING MATERIAL, POWDER COATING MATERIAL AND COATED ARTICLE | AGC INC (JP) | 2021-11-10 | — | — | EP | disclosed |
| US-11160770-B2 | Compounds, compositions and methods for treating oxidative DNA damage disorders | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2021-11-02 | — | — | US | disclosed |
| US-20210332189-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2021-10-28 | — | — | US | disclosed |
| CN-113549049-A | Polysubstituted thienocyclopentanone derivative and synthetic method thereof | 中国科学院大连化学物理研究所 | 2021-10-26 | — | — | CN | disclosed |
| EP-3878881-A2 | BINDERS | Knauf Insulation SPRL (BE) | 2021-09-15 | — | — | EP | disclosed |
| EP-3878444-A1 | ANTICANCER THERAPEUTIC AGENTS | RLL, LLC (US) | 2021-09-15 | — | — | EP | disclosed |
| EP-3875082-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | Endocyte, Inc. (US) | 2021-09-08 | — | — | EP | disclosed |
| US-20210253566-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. | 2021-08-19 | — | — | US | disclosed |
| US-20210253795-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2021-08-19 | — | — | US | disclosed |
| EP-3858341-A1 | PSMA LIGAND-CONTAINING CONJUGATES FOR THE TREATMENT OF PROSTATE CANCER | Endocyte, Inc. (US) | 2021-08-04 | — | — | EP | disclosed |
| US-11078332-B2 | Carbohydrate polyamine binders and materials made therewith | KNAUF INSULATION, INC. (US) | 2021-08-03 | — | — | US | disclosed |
| US-20210230201-A1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2021-07-29 | — | — | US | disclosed |
| US-20210222134-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2021-07-22 | — | — | US | disclosed |
| CN-108514646-B | Compounds for positron emission tomography | 恩多塞特公司 | 2021-07-16 | — | — | CN | disclosed |
| EP-2566903-B1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION (BE) | 2021-07-14 | — | — | EP | disclosed |
| EP-2566904-B1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION (BE) | 2021-07-14 | — | — | EP | disclosed |
| CN-106661418-B | Adhesive agent | 克瑙夫绝缘私人有限公司 | 2021-07-09 | — | — | CN | disclosed |
| CN-112961149-A | Cytochrome P450 inhibitors and uses thereof | 安吉恩生物医药公司 | 2021-06-15 | — | — | CN | disclosed |
| US-20210171712-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2021-06-10 | — | — | US | disclosed |
| US-20210171515-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. | 2021-06-10 | — | — | US | disclosed |
| US-20210154312-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE, INC. | 2021-05-27 | — | — | US | disclosed |
| US-20210155838-A1 | DUST AND INTEGRITY CONTROL COMPOSITIONS | MCTRON TECHNOLOGIES (US) | 2021-05-27 | — | — | US | disclosed |
| US-20210154311-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2021-05-27 | — | — | US | disclosed |
| US-20210137961-A1 | Compositions and Methods for Treating Dry Eye Diseases | CEMPRA PHARMACEUTICALS INC (US) | 2021-05-13 | — | — | US | disclosed |
| EP-3180335-B1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP (US) | 2021-05-05 | — | — | EP | disclosed |
| EP-2822386-B1 | FOLATE RECEPTOR ALPHA BINDING LIGANDS | PURDUE RESEARCH FOUNDATION (US) | 2021-05-05 | — | — | EP | disclosed |
| US-10995320-B2 | Biocatalysts for Ezetimibe synthesis | CODEXIS, INC. (US) | 2021-05-04 | — | — | US | disclosed |
| US-20210115164-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION SPRL (BE) | 2021-04-22 | — | — | US | disclosed |
| EP-2928935-B1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2021-03-31 | — | — | EP | disclosed |
| CN-107074841-B | Cytochrome P450 inhibitors and uses thereof | 安吉恩生物医药公司 | 2021-03-26 | — | — | CN | disclosed |
| US-20210087339-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2021-03-25 | — | — | US | disclosed |
| US-10953001-B2 | Methods for treating post traumatic stress disorder | AZEVAN PHARMACEUTICALS, INC. (US) | 2021-03-23 | — | — | US | disclosed |
| CN-108752241-B | Acylguanidines for the treatment of arthrosis | 默克专利股份公司 | 2021-03-12 | — | — | CN | disclosed |
| US-20210070797-A1 | PROCESSES FOR PREPARING FLUOROKETOLIDES | Têtard, Inc. (US) | 2021-03-11 | — | — | US | disclosed |
| EP-3777898-A2 | COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | Endocyte, Inc. (US) | 2021-02-17 | — | — | EP | disclosed |
| US-10912840-B2 | Conjugates for treating diseases caused by PSMA expressing cells | ENDOCYTE, INC. (US) | 2021-02-09 | — | — | US | disclosed |
| US-10913760-B2 | Carbohydrate binders and materials made therewith | KNAUF INSULATION, INC. (US) | 2021-02-09 | — | — | US | disclosed |
| EP-3280261-B1 | ANTICANCER THERAPEUTIC AGENTS | RLL LLC (US) | 2020-12-23 | — | — | EP | disclosed |
| EP-3351104-B1 | COMPOUNDS FOR USE IN THE TREATMENT OF INTERMITTENT EXPLOSIVE DISORDER | AZEVAN PHARMACEUTICALS INC (US) | 2020-12-09 | — | — | EP | disclosed |
| EP-2617088-B2 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION GMBH (US) | 2020-12-02 | — | — | EP | disclosed |
| US-20200362109-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2020-11-19 | — | — | US | disclosed |
| EP-3728444-A1 | BINDERS AND ASSOCIATED PRODUCTS | Knauf Insulation SPRL (BE) | 2020-10-28 | — | — | EP | disclosed |
| US-20200332060-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2020-10-22 | — | — | US | disclosed |
| CN-105102424-B | Acylguanidines for the treatment of arthrosis | 默克专利股份公司 | 2020-09-11 | — | — | CN | disclosed |
| US-20200283578-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2020-09-10 | — | — | US | disclosed |
| CN-111620974-A | Phosphorus-containing polyester electrolyte for high voltage lithium ion batteries | 罗伯特·博世有限公司 | 2020-09-04 | — | — | CN | disclosed |
| US-20200276150-A1 | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS | TETARD INC (US) | 2020-09-03 | — | — | US | disclosed |
| US-20200276167-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | AZEVAN PHARMACEUTICALS INC (US) | 2020-09-03 | — | — | US | disclosed |
| CN-107353870-B | High-folding LED packaging silica gel with high gas barrier property | 烟台德邦科技有限公司 | 2020-08-14 | — | — | CN | disclosed |
| CN-107353870-B | High-folding LED packaging silica gel with high gas barrier property | 烟台德邦科技有限公司 | 2020-08-14 | — | — | CN | disclosed |
| US-10738160-B2 | Carbohydrate polyamine binders and materials made therewith | KNAUF INSULATION SPRL (BE) | 2020-08-11 | — | — | US | disclosed |
| CN-111484449-A | Process for preparing dihalopyridines | 弗特鲁斯控股有限责任公司 | 2020-08-04 | — | — | CN | disclosed |
| EP-3681871-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | Azevan Pharmaceuticals, Inc. (US) | 2020-07-22 | — | — | EP | disclosed |
| US-20200215001-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2020-07-09 | — | — | US | disclosed |
| CN-111295373-A | Compositions and methods for treating brain injury | 阿泽凡药物公司 | 2020-06-16 | — | — | CN | disclosed |
| US-20200165389-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2020-05-28 | — | — | US | disclosed |
| US-20200123506-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2020-04-23 | — | — | US | disclosed |
| US-20200121801-A1 | DRUG DELIVERY CONJUGATES CONTAINING UNNATURAL AMINO ACIDS AND METHODS FOR USING | ENDOCYTE INC (US) | 2020-04-23 | — | — | US | disclosed |
| US-20200102294-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-04-02 | — | — | US | disclosed |
| US-20200079907-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2020-03-12 | — | — | US | disclosed |
| US-10556893-B2 | Cytochrome P450 inhibitors and uses thereof | ANGION BIOMEDICA CORP. (US) | 2020-02-11 | — | — | US | disclosed |
| US-20200040024-A1 | CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS | Têtard, Inc. (US) | 2020-02-06 | — | — | US | disclosed |
| US-10544400-B2 | Biocatalysts for ezetimibe synthesis | CODEXIS, INC. (US) | 2020-01-28 | — | — | US | disclosed |
| US-20190352323-A1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2019-11-21 | — | — | US | disclosed |
| US-20190352545-A1 | BINDERS AND ASSOCIATED PRODUCTS | Knauf Insulation Inc. (US) | 2019-11-21 | — | — | US | disclosed |
| US-20190352462-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2019-11-21 | — | — | US | disclosed |
| CN-107108795-B | Fluorine-containing pyrolytic resin, anti-corrosion agent composition, color filter protecting layer composition, etchant resist and color filter protecting layer | DIC株式会社 | 2019-11-05 | — | — | CN | disclosed |
| US-20190328759-A1 | PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | TETARD, INC. | 2019-10-31 | — | — | US | disclosed |
| US-10450462-B2 | Colored composition | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20190314515-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE, INC. | 2019-10-17 | — | — | US | disclosed |
| US-10420840-B2 | Anticancer therapeutic agents | RLL, LLC (US) | 2019-09-24 | — | — | US | disclosed |
| US-20190284337-A1 | BINDER | KNAUF INSULATION SPRL (BE) | 2019-09-19 | — | — | US | disclosed |
| US-10414760-B2 | Cytochrome P450 inhibitors and uses thereof | ANGION BIOMEDICA CORP. (US) | 2019-09-17 | — | — | US | disclosed |
| US-20190275181-A1 | Compounds for Positron Emission Tomography | ENDOCYTE INC (US) | 2019-09-12 | — | — | US | disclosed |
| CN-110225945-A | Composition and film | 大金工业株式会社 | 2019-09-10 | — | — | CN | disclosed |
| CN-110218456-A | Cyclohexyl LED encapsulation material and preparation method thereof | 广东信翼科技有限公司 | 2019-09-10 | — | — | CN | disclosed |
| EP-3533473-A2 | COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | Endocyte, Inc. (US) | 2019-09-04 | — | — | EP | disclosed |
| EP-3520860-A1 | QUINONE COMPOUNDS FOR TREATING APE1 MEDIATED DISEASES | Indiana University Research & Technology Corporation (US) | 2019-08-07 | — | — | EP | disclosed |
| CN-110088153-A | Composition, cured product, and laminate | DIC株式会社 | 2019-08-02 | — | — | CN | disclosed |
| US-10364236-B2 | Compositions and methods for treating neurodegenerative diseases | AZEVAN PHARMACEUTICALS, INC. (US) | 2019-07-30 | — | — | US | disclosed |
| EP-2855433-B1 | PROCESS FOR PREPARING DIHALOPYRIDINES | VERTELLUS HOLDINGS LLC (US) | 2019-07-24 | — | — | EP | disclosed |
| CN-110050008-A | polyisocyanate composition and coating composition | 旭化成株式会社 | 2019-07-23 | — | — | CN | disclosed |
| US-20190209530-A1 | POWDER ORAL SUSPENSION FORMULATIONS OF ANTIBACTERIAL AGENTS | TETARD, INC. | 2019-07-11 | — | — | US | disclosed |
| CN-109988466-A | Composition, coating, film, solar cell module back veneer and solar cell module | 大金氟化工（中国）有限公司 | 2019-07-09 | — | — | CN | disclosed |
| US-20190202987-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2019-07-04 | — | — | US | disclosed |
| US-10326077-B2 | Soluble graphene nanostructures and assemblies therefrom | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2019-06-18 | — | — | US | disclosed |
| US-10287462-B2 | Binders and associated products | KNAUF INSULATION, INC. (US) | 2019-05-14 | — | — | US | disclosed |
| US-20190119446-A1 | BINDERS | KNAUF INSULATION, INC. | 2019-04-25 | — | — | US | disclosed |
| CN-105960441-B | It is used to form the coating composition of the film with impact resistance | 关西涂料株式会社 | 2019-04-16 | — | — | CN | disclosed |
| US-20190099410-A1 | METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER | AZEVAN PHARMACEUTICALS INC (US) | 2019-04-04 | — | — | US | disclosed |
| CN-109563374-A | The manufacturing method of coating composition dispersion, aqueous composite particle dispersion and aqueous composite particle dispersion | 旭化成株式会社 | 2019-04-02 | — | — | CN | disclosed |
| US-20190085188-A1 | ENERGY CURABLE INKJET INKS FOR THE PRODUCTION OF LAYERED COMPOSITES | SUN CHEMICAL CORPORATION (US) | 2019-03-21 | — | — | US | disclosed |
| US-20190085128-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2019-03-21 | — | — | US | disclosed |
| WO-2019055913-A1 | COMPOSITIONS AND METHODS FOR TREATING BRAIN INJURY | AZEVAN PHARMACEUTICALS, INC. (US) | 2019-03-21 | — | — | WO | disclosed |
| CN-109476785-A | Fluoro-containing copolymer composition, fluorine resin coating, coated article | ＡＧＣ株式会社 | 2019-03-15 | — | — | CN | disclosed |
| US-10226452-B2 | Benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2019-03-12 | — | — | US | disclosed |
| CN-109415522-A | Film and its manufacturing method | ＡＧＣ株式会社 | 2019-03-01 | — | — | CN | disclosed |
| US-20190054059-A1 | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS | TETARD, INC. | 2019-02-21 | — | — | US | disclosed |
| EP-2718255-B1 | QUINONE COMPOUNDS FOR TREATING APE1 MEDIATED DISEASES | UNIV INDIANA RES & TECH CORP (US) | 2019-02-13 | — | — | EP | disclosed |
| US-20190038653-A1 | COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY DISEASES | TETARD, INC. | 2019-02-07 | — | — | US | disclosed |
| US-10188674-B2 | Parenteral formulations for administering macrolide antibiotics | CEMPRA PHARMACEUTICALS, INC. (US) | 2019-01-29 | — | — | US | disclosed |
| US-20190023731-A1 | CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS | TETARD, INC. | 2019-01-24 | — | — | US | disclosed |
| CN-109195999-A | Curable composition for photoimprint and pattern forming method using same | DIC株式会社 | 2019-01-11 | — | — | CN | disclosed |
| US-10172858-B2 | Combination pharmaceutical compositions and uses thereof | INTELLIKINE LLC (US) | 2019-01-08 | — | — | US | disclosed |
| US-10167370-B2 | Film, method for producing same, transparent conductive film, and touch panel | FUJIFILM CORPORATION (JP) | 2019-01-01 | — | — | US | disclosed |
| US-10159750-B2 | Immunogenic compositions and reagents for preparing | PURDUE RESEARCH FOUNDATION (US) | 2018-12-25 | — | — | US | disclosed |
| US-10154973-B2 | Quinone compounds for treating APE1 mediated diseases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-12-18 | — | — | US | disclosed |
| CN-108957956-A | Solidification compound, solidfied material, cured film, the manufacturing method of display panel and solidfied material | 东京应化工业株式会社 | 2018-12-07 | — | — | CN | disclosed |
| EP-3409683-A1 | BINDERS AND ASSOCIATED PRODUCTS | Knauf Insulation (BE) | 2018-12-05 | — | — | EP | disclosed |
| US-20180334455-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. (US) | 2018-11-22 | — | — | US | disclosed |
| CN-108779208-A | Polymer, composition, coating film, laminate, back sheet, and solar cell module | 大金工业株式会社 | 2018-11-09 | — | — | CN | disclosed |
| CN-108752241-A | Acyl group guanidine for treating arthropathy | 默克专利股份公司 | 2018-11-06 | — | — | CN | disclosed |
| US-20180312818-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2018-11-01 | — | — | US | disclosed |
| CN-108689989-A | A kind of DPP-4 inhibitor and its preparation and the application in diabetes | 孟晓旭 | 2018-10-23 | — | — | CN | disclosed |
| CN-108699361-A | Gloss-retaining polyfluoro copolymers for coating applications | 霍尼韦尔国际公司 | 2018-10-23 | — | — | CN | disclosed |
| CN-108675987-A | A kind of quinoline and its application in diabetes | 孟晓旭 | 2018-10-19 | — | — | CN | disclosed |
| CN-106414512-B | Method for producing aqueous fluoropolymer dispersion | 大金工业株式会社 | 2018-10-16 | — | — | CN | disclosed |
| CN-104812781-B | The manufacturing method of aqueous dispersion of polytetrafluoroethyland | 大金工业株式会社 | 2018-10-16 | — | — | CN | disclosed |
| US-20180289820-A1 | IMMUNOGENIC COMPOSITIONS AND REAGENTS FOR PREPARING | PURDUE RESEARCH FOUNDATION (US) | 2018-10-11 | — | — | US | disclosed |
| US-20180289826-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2018-10-11 | — | — | US | disclosed |
| CN-108603068-A | It is used to form the fluoropolymer solutions of fluoropolymer coating | 科慕埃弗西有限公司 | 2018-09-28 | — | — | CN | disclosed |
| CN-108602922-A | Fluorocopolymer for coating applications | 霍尼韦尔国际公司 | 2018-09-28 | — | — | CN | disclosed |
| US-20180271991-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2018-09-27 | — | — | US | disclosed |
| EP-2968801-B1 | METHODS FOR TREATING RESPIRATORY DISEASES AND FORMULATIONS THEREFOR | CEMPRA PHARMACEUTICALS INC (US) | 2018-09-26 | — | — | EP | disclosed |
| US-20180265633-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2018-09-20 | — | — | US | disclosed |
| US-20180256734-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2018-09-13 | — | — | US | disclosed |
| US-20180256735-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2018-09-13 | — | — | US | disclosed |
| US-20180256733-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2018-09-13 | — | — | US | disclosed |
| US-20180256736-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2018-09-13 | — | — | US | disclosed |
| US-20180256737-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE, INC. | 2018-09-13 | — | — | US | disclosed |
| WO-2018165266-A1 | COMPOSITIONS AND METHODS FOR TREATING DRY EYE DISEASES | CEMPRA PHARMACEUTICALS, INC. (US) | 2018-09-13 | — | — | WO | disclosed |
| EP-2825162-B1 | COMPOUNDS AND METHODS FOR TREATING LEUKEMIA | UNIV INDIANA RES & TECH CORP (US) | 2018-09-12 | — | — | EP | disclosed |
| CN-108484489-A | A kind of pyridine compounds and their of the substituent group containing adamantane and its purposes in the preparation of antitumor drugs | 陈海鹏 | 2018-09-04 | — | — | CN | disclosed |
| CN-108473781-A | The manufacturing method of electroconductive polymer dispersion liquid and its manufacturing method and conductive membrane | 信越聚合物株式会社 | 2018-08-31 | — | — | CN | disclosed |
| CN-105264010-B | Fluorin resin composition, film and article | 大金工业株式会社 | 2018-08-28 | — | — | CN | disclosed |
| WO-2018152424-A1 | TRIAZOLE-CONTAINING MACROLIDES AND OPHTHALMIC USES THEREFOR | CEMPRA PHARMACEUTICALS, INC. (US) | 2018-08-23 | — | — | WO | disclosed |
| CN-108424698-A | The method for forming multilayer film | 关西涂料株式会社 | 2018-08-21 | — | — | CN | disclosed |
| US-10053673-B2 | Biocatalysts for Ezetimibe synthesis | CODEXIS, INC. (US) | 2018-08-21 | — | — | US | disclosed |
| EP-3351104-A1 | COMPOUNDS FOR USE IN THE TREATMENT OF INTERMITTENT EXPLOSIVE DISORDER | Azevan Pharmaceuticals, Inc. (US) | 2018-07-25 | — | — | EP | disclosed |
| US-20180201608-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2018-07-19 | — | — | US | disclosed |
| CN-108276525-A | Amphiphilic core-shell porous polymer microsphere and preparation method thereof | 中国科学院理化技术研究所 | 2018-07-13 | — | — | CN | disclosed |
| US-10010618-B2 | Methods for treating cancer using combination therapies | ENDOCYTE, INC. (US) | 2018-07-03 | — | — | US | disclosed |
| US-10010616-B2 | Immunogenic compositions and reagents for preparing | PURDUE RESEARCH FOUNDATION (US) | 2018-07-03 | — | — | US | disclosed |
| EP-2252293-B1 | KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE LLC (US) | 2018-06-27 | — | — | EP | disclosed |
| US-10006913-B2 | Fluorescent-HAP: a diagnostic stain for HBV cores in cells | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-06-26 | — | — | US | disclosed |
| US-9988374-B2 | Cytochrome P450 inhibitors and uses thereof | ANGION BIOMEDICA CORP. (US) | 2018-06-05 | — | — | US | disclosed |
| US-9987265-B2 | Methods for treating post traumatic stress disorder | AZEVAN PHARMACEUTICALS, INC. (US) | 2018-06-05 | — | — | US | disclosed |
| US-20180148438-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP (US) | 2018-05-31 | — | — | US | disclosed |
| EP-2834256-B1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION (BE) | 2018-05-30 | — | — | EP | disclosed |
| CN-105086819-B | Aqueous coating agent composition, film and coated articles | 旭化成株式会社 | 2018-05-25 | — | — | CN | disclosed |
| CN-108070308-A | For the dumb light clear coating composition of aluminium parts | 关西涂料株式会社 | 2018-05-25 | — | — | CN | disclosed |
| EP-2922596-B1 | HETEROCYCLYL CARBOXAMIDES FOR TREATING VIRAL DISEASES | NOVADRUG LLC (US) | 2018-05-23 | — | — | EP | disclosed |
| US-20180133175-A1 | QUINONE COMPOUNDS FOR TREATING APE1 MEDIATED DISEASES | APEXIAN PHARMACEUTICALS, INC. | 2018-05-17 | — | — | US | disclosed |
| EP-3315522-A1 | THERMOSETTING COMPOSITIONS AND FORMING THREE-DIMENSIONAL OBJECTS THEREFROM | DSM IP Assets B.V. (NL) | 2018-05-02 | — | — | EP | disclosed |
| CN-104910383-B | Inorganic microparticle-dispersed liquid, inorganic microparticle-dispersed body, coating and solidfied material | DIC株式会社 | 2018-04-13 | — | — | CN | disclosed |
| CN-107910519-A | A kind of high power capacity high circulation number lithium ion battery | 江苏华富储能新技术股份有限公司 | 2018-04-13 | — | — | CN | disclosed |
| CN-107910520-A | A kind of lithium ion battery cathode slurry, negative material and preparation method thereof | 江苏华富储能新技术股份有限公司 | 2018-04-13 | — | — | CN | disclosed |
| US-20180100034-A1 | BINDER | KNAUF INSULATION SPRL (BE) | 2018-04-12 | — | — | US | disclosed |
| US-9937194-B1 | Compounds and methods for treating inflammatory diseases | CEMPRA PHARMACEUTICALS, INC. (US) | 2018-04-10 | — | — | US | disclosed |
| CN-107849329-A | Composition, coating film, fluorine-containing coating film, and laminate | 大金工业株式会社 | 2018-03-27 | — | — | CN | disclosed |
| CN-107844030-A | Anti-corrosion agent composition and corrosion-resisting pattern forming method | 东京应化工业株式会社 | 2018-03-27 | — | — | CN | disclosed |
| CN-107844031-A | Anti-corrosion agent composition and corrosion-resisting pattern forming method | 东京应化工业株式会社 | 2018-03-27 | — | — | CN | disclosed |
| EP-3292174-A1 | ENERGY CURABLE INKJET INKS FOR THE PRODUCTION OF LAYERED COMPOSITES | Sun Chemical Corporation (US) | 2018-03-14 | — | — | EP | disclosed |
| WO-2018045294-A1 | PROCESSES FOR PREPARING FLUOROKETOLIDES | CEMPRA PHARMACEUTICALS, INC. (US) | 2018-03-08 | — | — | WO | disclosed |
| CN-107768653-A | A kind of lithium ion battery cathode slurry, negative material, lithium ion battery and preparation method thereof | 申成利 | 2018-03-06 | — | — | CN | disclosed |
| CN-107732154-A | Small lithium ion battery of loss of capacitance and preparation method thereof after a kind of circulation electric discharge | 江苏华富储能新技术股份有限公司 | 2018-02-23 | — | — | CN | disclosed |
| US-20180044365-A1 | PROCESSES FOR PREPARING FLUOROKETOLIDES | TETARD, INC. | 2018-02-15 | — | — | US | disclosed |
| EP-3280261-A1 | ANTICANCER THERAPEUTIC AGENTS | RLL, LLC (US) | 2018-02-14 | — | — | EP | disclosed |
| US-9884814-B2 | Acylguanidines for treating osteoarthritis | MERCK PATENT GMBH (DE) | 2018-02-06 | — | — | US | disclosed |
| US-9877936-B2 | Quinone compounds for treating Ape1 mediated diseases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2018-01-30 | — | — | US | disclosed |
| CN-105308129-B | Paste compound and base material polishing method | 日本嘉柏微电子株式会社 | 2018-01-16 | — | — | CN | disclosed |
| EP-3265100-A1 | PROCESSES FOR PREPARING FLUOROKETOLIDES | Cempra Pharmaceuticals Inc. (US) | 2018-01-10 | — | — | EP | disclosed |
| US-9861616-B2 | Methods for treating respiratory diseases and formulations therefor | CEMPRA PHARMACEUTICALS, INC. (US) | 2018-01-09 | — | — | US | disclosed |
| US-20180002577-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION SPRL (BE) | 2018-01-04 | — | — | US | disclosed |
| CN-105705308-B | The manufacture method of mold release film and semiconductor package body | 旭硝子株式会社 | 2017-12-29 | — | — | CN | disclosed |
| US-20170360950-A1 | DRUG DELIVERY CONJUGATES CONTAINING UNNATURAL AMINO ACIDS AND METHODS FOR USING | ENDOCYTE INC (US) | 2017-12-21 | — | — | US | disclosed |
| US-20170355784-A1 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION INC (US) | 2017-12-14 | — | — | US | disclosed |
| CN-107429073-A | composition and laminate | 大金工业株式会社 | 2017-12-01 | — | — | CN | disclosed |
| CN-104892811-B | A kind of ethene chlorotrifluoroethylene, its preparation method and application | 浙江省化工研究院有限公司 | 2017-12-01 | — | — | CN | disclosed |
| EP-2831059-B1 | PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF | ENDOCYTE INC (US) | 2017-11-29 | — | — | EP | disclosed |
| US-9822301-B2 | Alkenyl ether compound and a liquid crystal composition using the same | DIC CORPORATION (JP) | 2017-11-21 | — | — | US | disclosed |
| US-9802925-B2 | Compositions and methods for treating neurodegenerative diseases | AZEVAN PHARMACEUTICALS, INC. (US) | 2017-10-31 | — | — | US | disclosed |
| US-20170304222-A1 | Compounds, Compositions and Methods for Treating Oxidative DNA Damage Disorders | INDIANA UNIV AND RES TECH CORP (US) | 2017-10-26 | — | — | US | disclosed |
| EP-2840076-B1 | BICYCLIC COMPOUND | TOA EIYO LTD (JP) | 2017-10-25 | — | — | EP | disclosed |
| CN-105813844-B | Coated article | 旭硝子株式会社 | 2017-10-24 | — | — | CN | disclosed |
| CN-104350115-B | The backboard and solar cell module of coating composition, solar cell module | 大金工业株式会社 | 2017-10-20 | — | — | CN | disclosed |
| CN-107250306-A | Coating film protective film | 琳得科株式会社 | 2017-10-13 | — | — | CN | disclosed |
| US-9782493-B2 | Conjugates for treating diseases caused by PSMA expressing cells | ENDOCYTE, INC. (US) | 2017-10-10 | — | — | US | disclosed |
| EP-3223860-A1 | METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES | Endocyte, Inc. (US) | 2017-10-04 | — | — | EP | disclosed |
| US-9771391-B2 | Process for preparing tubulysins | ENDOCYTE, INC. (US) | 2017-09-26 | — | — | US | disclosed |
| CN-107207819-A | Antifouling coating composition | 三菱化学株式会社 | 2017-09-26 | — | — | CN | disclosed |
| US-20170266303-A1 | METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES | PURDUE RESEARCH FOUNDATION | 2017-09-21 | — | — | US | disclosed |
| US-20170258932-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2017-09-14 | — | — | US | disclosed |
| US-9751908-B2 | Convergent processes for preparing macrolide antibacterial agents | CEMPRA PHARMACEUTICALS, INC. (US) | 2017-09-05 | — | — | US | disclosed |
| US-9751835-B2 | Processes and intermediates for preparing indole pharmaceuticals | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-09-05 | — | — | US | disclosed |
| CN-105431490-B | Composition comprising fluoropolymer containing at least one group selected from the group consisting of polymerizable functional group and crosslinkable functional group, and coated article | 大金工业株式会社 | 2017-09-01 | — | — | CN | disclosed |
| US-20170247363-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. (US) | 2017-08-31 | — | — | US | disclosed |
| CN-107108795-A | Fluorine-containing pyrolytic resin, anti-corrosion agent composition, color filter protecting layer composition, etchant resist and color filter protecting layer | DIC株式会社 | 2017-08-29 | — | — | CN | disclosed |
| EP-2168968-B1 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI PHARMACEUTICALS LLC (US) | 2017-08-23 | — | — | EP | disclosed |
| CN-107074841-A | Cytochrome P450 inhibitors and uses thereof | 安吉恩生物医药公司 | 2017-08-18 | — | — | CN | disclosed |
| CN-107078301-A | Binder for electricity storage device composition, electrode for power storage device mixture, electrode for power storage device and secondary cell | 旭硝子株式会社 | 2017-08-18 | — | — | CN | disclosed |
| CN-105086726-B | Aqueous coating agent composition, water paint, film and coated articles | 旭化成株式会社 | 2017-08-18 | — | — | CN | disclosed |
| US-20170226121-A1 | MODULATORS OF VIRUS ASSEMBLY AS ANTIVIRAL AGENTS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2017-08-10 | — | — | US | disclosed |
| US-20170224664-A1 | POWDER ORAL SUSPENSION FORMULATIONS OF ANTIBACTERIAL AGENTS | CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT | 2017-08-10 | — | — | US | disclosed |
| EP-2617088-B1 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION GMBH (US) | 2017-08-02 | — | — | EP | disclosed |
| CN-106994126-A | Use the therapeutic scheme of various medicaments | 因特利凯有限责任公司 | 2017-08-01 | — | — | CN | disclosed |
| US-20170209448-A1 | TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS | INTELLIKINE LLC | 2017-07-27 | — | — | US | disclosed |
| US-20170204378-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2017-07-20 | — | — | US | disclosed |
| EP-2611295-B1 | FUSED TRICYCLIC ETHER CARBAMATES AND THEIR USE | PURDUE RESEARCH FOUNDATION (US) | 2017-07-19 | — | — | EP | disclosed |
| CN-106924741-A | Use the therapeutic scheme of various medicaments | 因特利凯有限责任公司 | 2017-07-07 | — | — | CN | disclosed |
| US-20170190801-A1 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION INC (US) | 2017-07-06 | — | — | US | disclosed |
| EP-3185864-A1 | POWDER ORAL SUSPENSION FORMULATIONS OF ANTIBACTERIAL AGENTS | Cempra Pharmaceuticals, Inc. (US) | 2017-07-05 | — | — | EP | disclosed |
| CN-102985420-B | Cytochrome P 450 inhibitors and application thereof | 安吉翁生物医药有限公司 | 2017-07-04 | — | — | CN | disclosed |
| US-20170182010-A1 | BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2017-06-29 | — | — | US | disclosed |
| US-20170174836-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2017-06-22 | — | — | US | disclosed |
| US-20170174670-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | AZEVAN PHARMACEUTICALS, INC. (US) | 2017-06-22 | — | — | US | disclosed |
| EP-3180335-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | Angion Biomedica Corporation (US) | 2017-06-21 | — | — | EP | disclosed |
| US-9682990-B2 | Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors | PURDUE RESEARCH FOUNDATION (US) | 2017-06-20 | — | — | US | disclosed |
| US-9682141-B2 | Combination of kinase inhibitors and uses thereof | INTELLIKINE LLC (US) | 2017-06-20 | — | — | US | disclosed |
| US-20170165286-A1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND LIVER DISEASES | CORTLAND CAPITAL MARKET SERVICES LLC, AS AGENT | 2017-06-15 | — | — | US | disclosed |
| US-9669032-B2 | Enhanced treatment regimens using mTOR inhibitors | INTELLIKINE LLC (US) | 2017-06-06 | — | — | US | disclosed |
| US-20170152344-A1 | FUNCTIONAL GRAPHENE NANOSTRUCTURE DEVICES FROM LIVING POLYMERS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-01 | — | — | US | disclosed |
| US-9662402-B2 | Drug delivery conjugates containing unnatural amino acids and methods for using | ENDOCYTE, INC. (US) | 2017-05-30 | — | — | US | disclosed |
| US-20170130002-A1 | BINDERS | KNAUF INSULATION SPRL (BE) | 2017-05-11 | — | — | US | disclosed |
| EP-2544537-B1 | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS | CEMPRA PHARMACEUTICALS INC (US) | 2017-05-10 | — | — | EP | disclosed |
| CN-103703174-B | Combination pharmaceutical compositions and uses thereof | 因特利凯有限责任公司 | 2017-05-10 | — | — | CN | disclosed |
| CN-106619647-A | Combinations of kinase inhibitors and uses thereof | 因特利凯有限责任公司 | 2017-05-10 | — | — | CN | disclosed |
| US-9644189-B2 | Biocatalysts for ezetimibe synthesis | CODEXIS, INC. (US) | 2017-05-09 | — | — | US | disclosed |
| CN-103500767-B | Back sheet of solar cell | 大金工业株式会社 | 2017-05-03 | — | — | CN | disclosed |
| US-9637492-B2 | Benzothiazole kinase inhibitors and methods of use | INTELLIKINE LLC (US) | 2017-05-02 | — | — | US | disclosed |
| US-9636413-B2 | Conjugates for treating diseases caused by PSMA expressing cells | ENDOCYTE, INC. (US) | 2017-05-02 | — | — | US | disclosed |
| WO-2017070536-A1 | METHODS AND AGENTS FOR TREATING DISEASES | ANGION BIOMEDICA CORP. (US) | 2017-04-27 | — | — | WO | disclosed |
| US-9629918-B2 | Folate receptor alpha binding ligands | PURDUE RESEARCH FOUNDATION (US) | 2017-04-25 | — | — | US | disclosed |
| EP-3153023-A1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | Intellikine, LLC (US) | 2017-04-12 | — | — | EP | disclosed |
| CN-104710428-B | Benzoxazole kinase inhibitors and methods of use | 英特利凯恩有限责任公司 | 2017-04-12 | — | — | CN | disclosed |
| CN-103906816-B | Coating material, coating film, backsheet for solar cell module, and solar cell module | 大金工业株式会社 | 2017-04-12 | — | — | CN | disclosed |
| US-9617276-B2 | Compounds and methods for treating AIDS and HIV infections | PURDUE RESEARCH FOUNDATION (US) | 2017-04-11 | — | — | US | disclosed |
| US-20170095474-A1 | COMPOUNDS AND METHODS FOR TREATING MULTIPLE SCLEROSIS | PURDUE RESEARCH FOUNDATION (US) | 2017-04-06 | — | — | US | disclosed |
| EP-2542240-B1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | NOVADRUG LLC (US) | 2017-04-05 | — | — | EP | disclosed |
| EP-3146010-A1 | BINDERS | Knauf Insulation, Inc. (US) | 2017-03-29 | — | — | EP | disclosed |
| CN-105377903-B | The manufacture method of aqueous fluorine-containing polymer dispersion, aqueous fluorine-containing polymer dispersion and fluoropolymer | 旭硝子株式会社 | 2017-03-29 | — | — | CN | disclosed |
| EP-2957578-B1 | COLORED COMPOSITION | WAKO PURE CHEM IND LTD (JP) | 2017-03-22 | — | — | EP | disclosed |
| CN-104812735-B | Semicarbazide composition, method for producing semicarbazide composition, aqueous resin composition, and composite | 旭化成株式会社 | 2017-03-22 | — | — | CN | disclosed |
| US-20170065584-A1 | COMPOSITIONS AND USES THEREOF TO AMELIORATE PAIN | PURDUE RESEARCH FOUNDATION (US) | 2017-03-09 | — | — | US | disclosed |
| CN-104870581-B | Coating composition and method for forming multilayer coating film | 关西涂料株式会社 | 2017-03-08 | — | — | CN | disclosed |
| CN-106414512-A | Method for producing aqueous fluoropolymer dispersion | 大金工业株式会社 | 2017-02-15 | — | — | CN | disclosed |
| US-20170037187-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2017-02-09 | — | — | US | disclosed |
| EP-3122743-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | Azevan Pharmaceuticals, Inc. (US) | 2017-02-01 | — | — | EP | disclosed |
| US-20170015694-A1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION SPRL (BE) | 2017-01-19 | — | — | US | disclosed |
| EP-3105234-A1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND LIVER DISEASES | Cempra Pharmaceuticals, Inc. (US) | 2016-12-21 | — | — | EP | disclosed |
| EP-2705181-B1 | COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | INTELLIKINE LLC (US) | 2016-12-21 | — | — | EP | disclosed |
| US-20160361432-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (IN) | 2016-12-15 | — | — | US | disclosed |
| US-20160361433-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE INC (US) | 2016-12-15 | — | — | US | disclosed |
| US-20160361376-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE, INC. | 2016-12-15 | — | — | US | disclosed |
| CN-106221471-A | Coating | 东丽精细化工株式会社 | 2016-12-14 | — | — | CN | disclosed |
| US-9517237-B2 | Compounds and methods for treating multiple sclerosis | PURDUE RESEARCH FOUNDATION (US) | 2016-12-13 | — | — | US | disclosed |
| US-9511070-B2 | Heterocyclyl carboxamides for treating viral diseases | NOVADRUG, LLC (US) | 2016-12-06 | — | — | US | disclosed |
| US-9505883-B2 | Carbohydrate polyamine binders and materials made therewith | KNAUF INSULATION SPRL (BE) | 2016-11-29 | — | — | US | disclosed |
| US-9505747-B2 | Processes for preparing tubulysin derivatives and conjugates thereof | ENDOCYTE, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160339006-A1 | METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-11-24 | — | — | US | disclosed |
| CN-106147588-A | One group is applied to the aqueous finish paint of 25 type passenger vehicles, varnish and preparation method thereof | 成都拜迪新材料有限公司 | 2016-11-23 | — | — | CN | disclosed |
| US-9499558-B2 | Compounds and methods for treating HIV | PURDUE RESEARCH FOUNDATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-9499849-B2 | Processes for preparing tubulysins | ENDOCYTE, INC. (US) | 2016-11-22 | — | — | US | disclosed |
| US-9498477-B2 | Compositions and uses thereof to ameliorate pain | PURDUE RESEARCH FOUNDATION (US) | 2016-11-22 | — | — | US | disclosed |
| US-9493603-B2 | Carbohydrate binders and materials made therewith | KNAUF INSULATION SPRL (BE) | 2016-11-15 | — | — | US | disclosed |
| WO-2016179213-A1 | ENERGY CURABLE INKJET INKS FOR THE PRODUCTION OF LAYERED COMPOSITES | SUN CHEMICAL CORPORATION (US) | 2016-11-10 | — | — | WO | disclosed |
| US-20160326433-A1 | AN ALKENYL ETHER COMPOUND AND A LIQUID CRYSTAL COMPOSITION USING THE SAME | DIC CORPORATION (JP) | 2016-11-10 | — | — | US | disclosed |
| CN-106104753-A | The duplexer of oxygen plasma etch erosion resistant, etchant resist and use etchant resist | DIC株式会社 | 2016-11-09 | — | — | CN | disclosed |
| US-9487541-B2 | Fused tricyclic ether carbamates and their use | PURDUE RESEARCH FOUNDATION (US) | 2016-11-08 | — | — | US | disclosed |
| US-9487534-B2 | Modulators of virus assembly as antiviral agents | SCRIPPS RESEARCH INSTITUTE, A NOT-FOR-PROFIT PUBLIC BENEFIT CORPORATION OF CALIFORNIA (US) | 2016-11-08 | — | — | US | disclosed |
| US-20160318946-A1 | ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2016-11-03 | — | — | US | disclosed |
| US-9480679-B2 | Methods for treating malaria, tuberculosis and MAC diseases | CEMPRA PHARMACEUTICALS, INC. (US) | 2016-11-01 | — | — | US | disclosed |
| EP-2475253-B1 | METHODS FOR TREATING MALARIA, TUBERCULOSIS AND MAC DISEASES | CEMPRA PHARMACEUTICALS INC (US) | 2016-10-26 | — | — | EP | disclosed |
| CN-104245663-B | Bicyclic compounds | 东亚荣养株式会社 | 2016-10-26 | — | — | CN | disclosed |
| US-20160308134-A1 | SOLUBLE GRAPHENE NANOSTRUCTURES AND ASSEMBLIES THEREFROM | UNIV INDIANA RES & TECH CORP (US) | 2016-10-20 | — | — | US | disclosed |
| CN-103958627-B | Coating, film, the backboard of solar module and solar module | 大金工业株式会社 | 2016-10-19 | — | — | CN | disclosed |
| US-20160296630-A1 | METHODS FOR TREATING CANCER USING COMBINATION THERAPIES | ENDOCYTE INC (US) | 2016-10-13 | — | — | US | disclosed |
| US-20160296482-A1 | ANTICANCER THERAPEUTIC AGENTS | RLL, LLC | 2016-10-13 | — | — | US | disclosed |
| WO-2016164707-A1 | ANTICANCER THERAPEUTIC AGENTS | RLL, LLC (US) | 2016-10-13 | — | — | WO | disclosed |
| CN-103491962-B | Combinations of kinase inhibitors and uses thereof | 因特利凯有限责任公司 | 2016-10-12 | — | — | CN | disclosed |
| US-20160287597-A1 | Treatment Regimens Using Multiple Pharmaceutical Agents | INTELLIKINE LLC | 2016-10-06 | — | — | US | disclosed |
| US-20160287731-A1 | Compounds for Positron Emission Tomography | ENDOCYTE, INC | 2016-10-06 | — | — | US | disclosed |
| US-20160287595-A1 | Combination Pharmaceutical Compositions and Uses Thereof | CALITHERA BIOSCIENCES, INC. | 2016-10-06 | — | — | US | disclosed |
| US-20160287596-A1 | Benzoxazole Kinase Inhibitors and Methods of Use | FAETH THERAPEUTICS, INC. | 2016-10-06 | — | — | US | disclosed |
| WO-2016153874-A1 | COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE | PURDUE RESEARCH FOUNDATION (US) | 2016-09-29 | — | — | WO | disclosed |
| US-20160281068-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2016-09-29 | — | — | US | disclosed |
| US-20160279079-A1 | COMPOSITIONS AND METHODS FOR TREATING BONE DISEASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2016-09-29 | — | — | US | disclosed |
| US-20160280971-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION SPRL (BE) | 2016-09-29 | — | — | US | disclosed |
| CN-104204804-B | Combinations of kinase inhibitors and uses thereof | 因特利凯有限责任公司 | 2016-09-28 | — | — | CN | disclosed |
| US-20160274112-A1 | FLUORESCENT-HAP: A DIAGNOSTIC STAIN FOR HBV CORES IN CELLS | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2016-09-22 | — | — | US | disclosed |
| EP-3069147-A1 | COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | Endocyte, Inc. (US) | 2016-09-21 | — | — | EP | disclosed |
| WO-2016144833-A1 | PROCESSES FOR PREPARING FLUOROKETOLIDES | CEMPRA PHARMACEUTICALS, INC. (US) | 2016-09-15 | — | — | WO | disclosed |
| US-20160244580-A1 | FILM, METHOD FOR PRODUCING SAME, TRANSPARENT CONDUCTIVE FILM, AND TOUCH PANEL | FUJIFILM CORPORATION (JP) | 2016-08-25 | — | — | US | disclosed |
| US-20160235758-A1 | COMBINATION OF MTOR INHIBITORS AND PI3-KINASE INHIBITORS, AND USES THEREOF | INTELLIKINE LLC | 2016-08-18 | — | — | US | disclosed |
| CN-105873960-A | Aqueous composite particle dispersion | 旭化成株式会社 | 2016-08-17 | — | — | CN | disclosed |
| EP-2747765-B1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | NOVADRUG LLC (US) | 2016-08-10 | — | — | EP | disclosed |
| CN-103392221-B | Curing combination for nanometer stamping, nano impression formed body and pattern formation method | DIC株式会社 | 2016-08-10 | — | — | CN | disclosed |
| US-9410040-B2 | Soluble graphene nanostructures and assemblies therefrom | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2016-08-09 | — | — | US | disclosed |
| CN-105829367-A | CURABLE FLUOROCOPOLYMER FORMED FROM TETRAFLUOROPROPENE | 霍尼韦尔国际公司 | 2016-08-03 | — | — | CN | disclosed |
| US-9388391-B2 | Biocatalysts for Ezetimibe synthesis | CODEXIS, INC. (US) | 2016-07-12 | — | — | US | disclosed |
| US-9376424-B2 | Methods for treating post traumatic stress disorder | AZEVAN PHARMACEUTICALS, INC. (US) | 2016-06-28 | — | — | US | disclosed |
| US-9376406-B2 | uPAR-uPA interaction inhibitors and methods for treating cancer | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2016-06-28 | — | — | US | disclosed |
| US-20160177363-A1 | PROCESSES FOR PREPARING TUBULYSINS | ENDOCYTE INC (US) | 2016-06-23 | — | — | US | disclosed |
| US-20160166521-A1 | Compounds, Compositions and Methods for Treating Oxidative DNA Damage Disorders | INDIANA UNIVERSITY AND RES TECHNOLOGY CORP (US) | 2016-06-16 | — | — | US | disclosed |
| US-9364543-B2 | Visible light curable hydrogels and methods for using | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2016-06-14 | — | — | US | disclosed |
| WO-2016085967-A1 | METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES | ENDOCYTE, INC. (US) | 2016-06-02 | — | — | WO | disclosed |
| US-9345706-B2 | Benzoxazole kinase inhibitors and methods of use | INTELLIKINE, LLC (US) | 2016-05-24 | — | — | US | disclosed |
| US-9328073-B2 | Alcohol-, diol-, and carbohydrate-substituted indenoisoquinolines as topoisomerase I inhibitors | PURDUE RESEARCH FOUNDATION (US) | 2016-05-03 | — | — | US | disclosed |
| US-20160107991-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING INDOLE PHARMACEUTICALS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION | 2016-04-21 | — | — | US | disclosed |
| US-9315481-B2 | Compounds and methods for treating leukemia | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2016-04-19 | — | — | US | disclosed |
| CN-103097925-B | Diffraction optical element and measuring device | ASAHI GLASS CO.,LTD. (JP) | 2016-04-13 | — | — | CN | disclosed |
| US-9309213-B2 | C-3 substituted bicyclooctane based HIV protease inhibitors | PURDUE RESEARCH FOUNDATION (US) | 2016-04-12 | — | — | US | disclosed |
| US-9303059-B2 | Chemoselective enrichment for compound isolation | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2016-04-05 | — | — | US | disclosed |
| US-20160089371-A1 | Combination of Kinase Inhibitors and Uses Thereof | INTELLIKINE LLC | 2016-03-31 | — | — | US | disclosed |
| CN-103172657-B | Containing the functionalized cage modle polyhedral polysilsesquioxane and preparation method thereof of alkynyl | BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY (CN) | 2016-03-30 | — | — | CN | disclosed |
| US-9295673-B2 | Combination of mTOR inhibitors and P13-kinase inhibitors, and uses thereof | INTELLIKINE LLC (US) | 2016-03-29 | — | — | US | disclosed |
| US-9290440-B2 | Bicyclic compound | TOA EIYO LTD. (JP) | 2016-03-22 | — | — | US | disclosed |
| US-9273091-B2 | Processes for preparing tubulysins | ENDOCYTE, INC. (US) | 2016-03-01 | — | — | US | disclosed |
| US-20160045461-A1 | QUINONE COMPOUNDS FOR TREATING APE1 MEDIATED DISEASES | APEXIAN PHARMACEUTICALS, INC. | 2016-02-18 | — | — | US | disclosed |
| WO-2016025424-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORPORATION (US) | 2016-02-18 | — | — | WO | disclosed |
| US-20160046660-A1 | CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS | TETARD, INC. | 2016-02-18 | — | — | US | disclosed |
| US-20160040013-A1 | COLORED COMPOSITION | WAKO PURE CHEMICAL INDUSTRIES, LTD. (JP) | 2016-02-11 | — | — | US | disclosed |
| US-20160038490-A1 | COMPOSITIONS AND METHODS FOR TREATING DYSPROLIFERATIVE DISEASES | ANGION BIOMEDICA CORP. (US) | 2016-02-11 | — | — | US | disclosed |
| WO-2016022658-A1 | POWDER ORAL SUSPENSION FORMULATIONS OF ANTIBACTERIAL AGENTS | CEMPRA PHARMACEUTICALS, INC. (US) | 2016-02-11 | — | — | WO | disclosed |
| US-20160038497-A1 | Enhanced Treatment Regimens Using mTOR Inhibitors | FAETH THERAPEUTICS, INC. | 2016-02-11 | — | — | US | disclosed |
| CN-103259044-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORP. (JP) | 2016-02-10 | — | — | CN | disclosed |
| US-20160030396-A1 | METHODS FOR TREATING RESPIRATORY DISEASES AND FORMULATIONS THEREFOR | TETARD, INC. | 2016-02-04 | — | — | US | disclosed |
| EP-2976083-A2 | FLUORESCENT-HAP: A DIAGNOSTIC STAIN FOR HBV CORES IN CELLS | Indiana University Research and Technology Corporation (US) | 2016-01-27 | — | — | EP | disclosed |
| US-9241930-B2 | Compositions and methods for treating viral diseases | NOVADRUG, LLC (US) | 2016-01-26 | — | — | US | disclosed |
| US-20160016993-A1 | PROCESS FOR PREPARING TUBULYSINS | ENDOCYTE, INC. | 2016-01-21 | — | — | US | disclosed |
| US-20160017063-A1 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION INC (US) | 2016-01-21 | — | — | US | disclosed |
| EP-2968801-A1 | METHODS FOR TREATING RESPIRATORY DISEASES AND FORMULATIONS THEREFOR | Cempra Pharmaceuticals, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2968340-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | Intellikine, LLC (US) | 2016-01-20 | — | — | EP | disclosed |
| EP-2968384-A1 | CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS | Cempra Pharmaceuticals, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| CN-103102251-B | Radiation-ray sensitive composition | MITSUBISHI GAS CHEMICAL INC. (JP) | 2016-01-20 | — | — | CN | disclosed |
| CN-105246482-A | Combinations of kinase inhibitors and uses thereof | INTELLIKINE LLC | 2016-01-13 | — | — | CN | disclosed |
| EP-2961764-A1 | PROCESSES FOR PREPARING TUBULYSINS | Endocyte, Inc. (US) | 2016-01-06 | — | — | EP | disclosed |
| EP-2957578-A1 | COLORED COMPOSITION | Wako Pure Chemical Industries, Ltd. (JP) | 2015-12-23 | — | — | EP | disclosed |
| US-20150361037-A1 | ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS | MERCK PATENT GMBH (DE) | 2015-12-17 | — | — | US | disclosed |
| EP-2954025-A1 | METHOD FOR FORMING THERMALLY CONDUCTIVE THERMAL RADICAL CURE SILICONE COMPOSITIONS | Dow Corning Corporation (US) | 2015-12-16 | — | — | EP | disclosed |
| US-9206193-B2 | Substituted norindenoisoquinolines, syntheses thereof, and methods of use | PURDUE RESEARCH FOUNDATION (US) | 2015-12-08 | — | — | US | disclosed |
| US-20150342977-A1 | PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | TETARD, INC. | 2015-12-03 | — | — | US | disclosed |
| WO-2015177114-A1 | BINDERS | KNAUF INSULATION, LLC (US) | 2015-11-26 | — | — | WO | disclosed |
| EP-2945929-A1 | ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS | Merck Patent GmbH (DE) | 2015-11-25 | — | — | EP | disclosed |
| CN-105102424-A | Acylguanidines for the treatment of arthrosis | MERCK PATENT GMBH | 2015-11-25 | — | — | CN | disclosed |
| US-9193683-B2 | Process for preparing dihalopyridines | VERTELLUS SPECIALTIES INC. (US) | 2015-11-24 | — | — | US | disclosed |
| US-9193700-B2 | Quinone compounds for treating Ape1 mediated diseases | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-11-24 | — | — | US | disclosed |
| WO-2015173168-A1 | BENZOXAZOLONE DERIVATIVES AS ACID CERAMIDASE INHIBITORS, AND THEIR USE AS MEDICAMENTS | FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA (IT) | 2015-11-19 | — | — | WO | disclosed |
| US-20150315339-A1 | BINDER | KNAUF INSULATION SPRL (BE) | 2015-11-05 | — | — | US | disclosed |
| US-9174994-B2 | Enhanced treatment regimens using mTor inhibitors | INTELLIKINE, LLC (US) | 2015-11-03 | — | — | US | disclosed |
| US-20150306105-A1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | FAETH THERAPEUTICS, INC. | 2015-10-29 | — | — | US | disclosed |
| US-20150297735-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE, INC. | 2015-10-22 | — | — | US | disclosed |
| US-20150299391-A1 | BINDERS | Knauf Insulation ,LLC | 2015-10-22 | — | — | US | disclosed |
| US-20150292045-A1 | ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS | ASSEMBLY BIOSCIENCES, INC. | 2015-10-15 | — | — | US | disclosed |
| EP-2928936-A2 | BINDER | Knauf Insulation SPRL (BE) | 2015-10-14 | — | — | EP | disclosed |
| EP-2928935-A2 | BINDERS | Knauf Insulation SPRL (BE) | 2015-10-14 | — | — | EP | disclosed |
| WO-2015148962-A1 | COMPOSITIONS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES | AZEVAN PHARMACEUTICALS, INC. (US) | 2015-10-01 | — | — | WO | disclosed |
| EP-2922596-A2 | HETEROCYCLYL CARBOXAMIDES FOR TREATING VIRAL DISEASES | Novadrug, LLC (US) | 2015-09-30 | — | — | EP | disclosed |
| EP-2919774-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | Endocyte, Inc. (US) | 2015-09-23 | — | — | EP | disclosed |
| US-20150258203-A1 | DRUG DELIVERY CONJUGATES CONTAINING UNNATURAL AMINO ACIDS AND METHODS FOR USING | ENDOCYTE, INC. | 2015-09-17 | — | — | US | disclosed |
| EP-2917184-A1 | ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS | Indiana University Research and Technology Corporation (US) | 2015-09-16 | — | — | EP | disclosed |
| US-20150246041-A1 | COMPOUNDS AND METHODS FOR TREATING MULTIPLE SCLEROSIS | NEURO VIGOR LLC (US) | 2015-09-03 | — | — | US | disclosed |
| US-20150238489-A1 | HETEROCYCLYL CARBOXAMIDES FOR TREATING VIRAL DISEASES | NOVADRUG, LLC | 2015-08-27 | — | — | US | disclosed |
| EP-2908818-A2 | DRUG DELIVERY CONJUGATES CONTAINING UNNATURAL AMINO ACIDS AND METHODS FOR USING | Endocyte, Inc. (US) | 2015-08-26 | — | — | EP | disclosed |
| WO-2015123256-A1 | COMPOSITIONS AND METHODS FOR TREATING DIABETES AND LIVER DISEASES | CEMPRA PHARMACEUTICALS, INC. (US) | 2015-08-20 | — | — | WO | disclosed |
| US-20150225414-A1 | COMPOUNDS AND METHODS FOR TREATING HIV | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-08-13 | — | — | US | disclosed |
| US-20150225407-A1 | Benzothiazole Kinase Inhibitors and Methods of Use | INTELLIKINE LLC | 2015-08-13 | — | — | US | disclosed |
| US-20150225447-A1 | PROCESSES FOR PREPARING TUBULYSINS | ENDOCYTE, INC. (US) | 2015-08-13 | — | — | US | disclosed |
| US-20150218527-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | INNOVATUS LIFE SCIENCES LENDING FUND I, LP, AS COLLATERAL AGENT | 2015-08-06 | — | — | US | disclosed |
| US-20150218182-A1 | MODULATORS OF VIRUS ASSEMBLY AS ANTIVIRAL AGENTS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-08-06 | — | — | US | disclosed |
| EP-2566497-B1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | CODEXIS INC (US) | 2015-07-29 | — | — | EP | disclosed |
| US-9090593-B2 | Bicyclic compounds as Pim inhibitors | AMGEN INC. (US) | 2015-07-28 | — | — | US | disclosed |
| US-9085590-B2 | Protecting groups for boronic acids | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2015-07-21 | — | — | US | disclosed |
| US-9079983-B2 | Chemoselective enrichment for compound isolation | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2015-07-14 | — | — | US | disclosed |
| US-9073920-B2 | Substituted dibenzonaphthyridines, pharmaceutical uses thereof and processes therfor | PURDUE RESEARCH FOUNDATION (US) | 2015-07-07 | — | — | US | disclosed |
| US-20150164907-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASE | ANGION BIOMEDICA CORP. (US) | 2015-06-18 | — | — | US | disclosed |
| CN-104710428-A | Benzoxazole kinase inhibitors and methods of use | INTELLIKINE INC | 2015-06-17 | — | — | CN | disclosed |
| US-9056109-B2 | Compounds and methods for treating multiple sclerosis | PURDUE RESEARCH FOUNDATION (US) | 2015-06-16 | — | — | US | disclosed |
| US-9056099-B2 | Compositions and methods for treating viral diseases | NOVADRUG, LLC (US) | 2015-06-16 | — | — | US | disclosed |
| US-20150158853-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP (US) | 2015-06-11 | — | — | US | disclosed |
| US-20150152055-A1 | PROCESS FOR PREPARING DIHALOPYRIDINES | VERTELLUS SPECOALTIES INC. (US) | 2015-06-04 | — | — | US | disclosed |
| CN-104685019-A | Radically curable adhesive composition and polarizing plate comprising same | LG CHEMICAL LTD | 2015-06-03 | — | — | CN | disclosed |
| CN-104685392-A | Polarizing plate | LG CHEMICAL LTD | 2015-06-03 | — | — | CN | disclosed |
| US-20150148370-A1 | ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2015-05-28 | — | — | US | disclosed |
| US-9040262-B2 | Biocatalysts for ezetimibe synthesis | CODEXIS, INC. (US) | 2015-05-26 | — | — | US | disclosed |
| WO-2015073678-A1 | COMPOUNDS FOR POSITRON EMISSION TOMOGRAPHY | ENDOCYTE, INC. (US) | 2015-05-21 | — | — | WO | disclosed |
| US-9024038-B2 | Compunds and methods for treating HIV | PURDUE RESEARCH FOUNDATION (US) | 2015-05-05 | — | — | US | disclosed |
| US-20150119418-A1 | BICYCLIC COMPOUND | TOA EIYO LTD. (JP) | 2015-04-30 | — | — | US | disclosed |
| US-20150111962-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2015-04-23 | — | — | US | disclosed |
| US-20150112061-A1 | COMPOSITIONS AND USES THEREOF TO AMELIORATE PAIN | PURDUE RESEARCH FOUNDATION (US) | 2015-04-23 | — | — | US | disclosed |
| US-20150105324-A1 | COMPOSITIONS AND METHODS FOR TREATING PTSD AND RELATED DISEASES | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2015-04-16 | — | — | US | disclosed |
| EP-2855433-A2 | PROCESS FOR PREPARING DIHALOPYRIDINES | Vertellus Specialties Inc. (US) | 2015-04-08 | — | — | EP | disclosed |
| US-8993580-B2 | Benzothiazole kinase inhibitors and methods of use | INTELLIKINE LLC (US) | 2015-03-31 | — | — | US | disclosed |
| US-20150087627-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | INTELLIKINE LLC (US) | 2015-03-26 | — | — | US | disclosed |
| EP-2841063-A2 | COMPOSITIONS AND METHODS FOR TREATING PTSD AND RELATED DISEASES | Indiana University Research and Technology Corporation (US) | 2015-03-04 | — | — | EP | disclosed |
| US-20150053114-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION (BE) | 2015-02-26 | — | — | US | disclosed |
| EP-2840076-A1 | BICYCLIC COMPOUND | TOA Eiyo Ltd. (JP) | 2015-02-25 | — | — | EP | disclosed |
| US-20150051399-A1 | PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF | ENDOCYTE, INC. | 2015-02-19 | — | — | US | disclosed |
| CN-104363914-A | Enhanced treatment regimens using mtor inhibitors | INTELLIKINE LLC | 2015-02-18 | — | — | CN | disclosed |
| US-20150045435-A1 | COMPOUNDS AND METHODS FOR TREATING DIABETES | UNIV INDIANA RES & TECH CORP (US) | 2015-02-12 | — | — | US | disclosed |
| EP-2834256-A1 | BINDERS AND ASSOCIATED PRODUCTS | Knauf Insulation (BE) | 2015-02-11 | — | — | EP | disclosed |
| EP-2830632-A1 | PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | Cempra Pharmaceuticals, Inc. (US) | 2015-02-04 | — | — | EP | disclosed |
| EP-2831059-A1 | PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF | Endocyte, Inc. (US) | 2015-02-04 | — | — | EP | disclosed |
| CN-102271513-B | Benzoxazole kinase inhibitors and methods of use | INTELLIKINE INC | 2015-02-04 | — | — | CN | disclosed |
| US-8946220-B2 | Compositions and uses thereof to ameliorate pain | PURDUE RESEARCH FOUNDATION (US) | 2015-02-03 | — | — | US | disclosed |
| US-20150030588-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | INTELLIKINE LLC | 2015-01-29 | — | — | US | disclosed |
| US-20150023874-A1 | FOLATE RECEPTOR ALPHA BINDING LIGANDS | PURDUE RESEARCH FOUNDATION | 2015-01-22 | — | — | US | disclosed |
| US-20150023987-A1 | IMMUNOGENIC COMPOSITIONS AND REAGENTS FOR PREPARING | PURDUE RESEARCH FOUNDATION (US) | 2015-01-22 | — | — | US | disclosed |
| EP-2825162-A1 | COMPOUNDS AND METHODS FOR TREATING LEUKEMIA | Indiana University Research and Technology Corporation (US) | 2015-01-21 | — | — | EP | disclosed |
| EP-2822386-A1 | FOLATE RECEPTOR ALPHA BINDING LIGANDS | Purdue Research Foundation (US) | 2015-01-14 | — | — | EP | disclosed |
| US-8921349-B2 | Compounds and methods for treating AIDS and HIV infections | PURDUE RESEARCH FOUNDATION (US) | 2014-12-30 | — | — | US | disclosed |
| US-20140377285-A1 | TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS | INTELLIKINE LLC | 2014-12-25 | — | — | US | disclosed |
| CN-104245663-A | Bicyclic compounds | TOA EIYO LTD | 2014-12-24 | — | — | CN | disclosed |
| CN-104204804-A | Combinations of kinase inhibitors and uses thereof | INTELLIKINE LLC | 2014-12-10 | — | — | CN | disclosed |
| US-20140357651-A1 | COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | CALITHERA BIOSCIENCES, INC. | 2014-12-04 | — | — | US | disclosed |
| WO-2014186325-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING INDOLE PHARMACEUTICALS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2014-11-20 | — | — | WO | disclosed |
| US-8889880-B2 | Processes for preparing tubulysins | ENDOCYTE, INC. (US) | 2014-11-18 | — | — | US | disclosed |
| US-20140329871-A1 | SMALL MOLECULE ANTI-FIBROTIC COMPOUNDS AND USES THEREOF | ANGION BIOMEDICA CORP. (US) | 2014-11-06 | — | — | US | disclosed |
| CN-102924458-B | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI PHARM INC | 2014-11-05 | — | — | CN | disclosed |
| US-20140323618-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION (BE) | 2014-10-30 | — | — | US | disclosed |
| EP-2796456-A1 | Bicyclic compounds as Pim inhibitors | Amgen Inc. (US) | 2014-10-29 | — | — | EP | disclosed |
| EP-2793893-A2 | ENHANCED TREATMENT REGIMENS USING MTOR INHIBITORS | Intellikine, LLC (US) | 2014-10-29 | — | — | EP | disclosed |
| US-8865752-B2 | Cytochrome P450 inhibitors and uses thereof | ANGION BIOMEDICA CORP. (US) | 2014-10-21 | — | — | US | disclosed |
| US-20140309234-A1 | SMALL MOLECULE ANTI-FIBROTIC COMPOUNDS AND USES THEREOF | ANGION BIOMEDICA CORP (US) | 2014-10-16 | — | — | US | disclosed |
| CN-104080786-A | Treatment regimens using multiple agents | INTELLIKINE LLC | 2014-10-01 | — | — | CN | disclosed |
| CN-102097654-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEMICAL CORP. (JP) | 2014-10-01 | — | — | CN | disclosed |
| WO-2014149973-A2 | COMPOSITIONS AND METHODS FOR TREATING BONE DISEASES | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014153459-A2 | FLUORESCENT-HAP: A DIAGNOSTIC STAIN FOR HBV CORES IN CELLS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014153041-A1 | PROTECTING GROUPS FOR BORONIC ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014151147-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2014-09-25 | — | — | WO | disclosed |
| US-20140287031-A1 | ENHANCED TREATMENT REGIMENS USING MTOR INHIBITORS | INTELLIKINE, LLC (US) | 2014-09-25 | — | — | US | disclosed |
| WO-2014152326-A1 | METHODS FOR TREATING RESPIRATORY DISEASES AND FORMULATIONS THEREFOR | CEMPRA PHARMACEUTICALS, INC. (US) | 2014-09-25 | — | — | WO | disclosed |
| WO-2014145210-A1 | CONVERGENT PROCESSES FOR PREPARING MACROLIDE ANTIBACTERIAL AGENTS | CEMPRA PHARMACEUTICALS, INC. (US) | 2014-09-18 | — | — | WO | disclosed |
| US-20140275601-A1 | PROTECTING GROUPS FOR BORONIC ACIDS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-09-18 | — | — | US | disclosed |
| EP-2776441-A1 | TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS | Intellikine, LLC (US) | 2014-09-17 | — | — | EP | disclosed |
| EP-2776837-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | Intellikine, LLC (US) | 2014-09-17 | — | — | EP | disclosed |
| US-8835457-B2 | Bridged bicyclic RHO kinase inhibitor compounds, compositions and use | MERCK SHARP & DOHME CORP. (US) | 2014-09-16 | — | — | US | disclosed |
| WO-2014134543-A1 | PROCESSES FOR PREPARING TUBULYSINS | ENDOCYTE, INC. (US) | 2014-09-04 | — | — | WO | disclosed |
| US-20140249315-A1 | PROCESSES FOR PREPARING TUBULYSINS | ENDOCYTE, INC. | 2014-09-04 | — | — | US | disclosed |
| US-20140249178-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | NOVADRUG, LLC (US) | 2014-09-04 | — | — | US | disclosed |
| US-8815878-B1 | Spiro hemiaminals for treating viral diseases | NOVADRUG, LLC (US) | 2014-08-26 | — | — | US | disclosed |
| WO-2014124367-A1 | METHOD FOR FORMING THERMALLY CONDUCTIVE THERMAL RADICAL CURE SILICONE COMPOSITIONS | DOW CORNING CORPORATION (US) | 2014-08-14 | — | — | WO | disclosed |
| US-8802724-B2 | Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans | PURDUE RESEARCH FOUNDATION (US) | 2014-08-12 | — | — | US | disclosed |
| EP-2760898-A1 | PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2014-08-06 | — | — | EP | disclosed |
| WO-2014111113-A1 | ACYLGUANIDINES FOR TREATING OSTEOARTHRITIS | MERCK PATENT GMBH (DE) | 2014-07-24 | — | — | WO | disclosed |
| EP-2747765-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | Novadrug, LLC (US) | 2014-07-02 | — | — | EP | disclosed |
| US-20140179754-A1 | FUSED TRICYCLIC ETHER CARBAMATES AND THEIR USE | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2014-06-26 | — | — | US | disclosed |
| WO-2014093960-A1 | COMPOSITIONS AND METHODS FOR TREATING DISEASE | ANGION BIOMEDICA CORP. (US) | 2014-06-19 | — | — | WO | disclosed |
| WO-2014086775-A2 | BINDERS | KNAUF INSULATION (BE) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014086777-A2 | BINDER | KNAUF INSULATION (BE) | 2014-06-12 | — | — | WO | disclosed |
| WO-2014085575-A1 | METHODS FOR TREATING CANCER USING COMBINATION THERAPIES | ENDOCYTE, INC. (US) | 2014-06-05 | — | — | WO | disclosed |
| US-20140154702-A1 | Methods For Treating Cancer Using Combination Therapies | ENDOCYTE INC (US) | 2014-06-05 | — | — | US | disclosed |
| US-20140148508-A1 | C-3 SUBSTITUTED BICYCLOOCTANE BASED HIV PROTEASE INHIBITORS | NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (JP) | 2014-05-29 | — | — | US | disclosed |
| US-8735405-B2 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI Pharmaceuticals, LLC (US) | 2014-05-27 | — | — | US | disclosed |
| WO-2014078484-A1 | CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS | ENDOCYTE, INC. (US) | 2014-05-22 | — | — | WO | disclosed |
| US-20140142319-A1 | ORGANOACTINIDE-, ORGANOLANTHANIDE-, AND ORGANOGROUP-4-MEDIATED HYDROTHIOLATION OF TERMINAL ALKYNES WITH ALIPHATIC, AROMATIC AND BENZYLIC THIOLS | NORTHWESTERN UNIVERSITY (US) | 2014-05-22 | — | — | US | disclosed |
| WO-2014074906-A1 | ALTERNATIVE USES FOR HBV ASSEMBLY EFFECTORS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2014-05-15 | — | — | WO | disclosed |
| CN-103796655-A | Treatment of polycystic disease | UNIV CALIFORNIA | 2014-05-14 | — | — | CN | disclosed |
| US-20140128398-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2014-05-08 | — | — | US | disclosed |
| US-20140128599-A1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE LLC (US) | 2014-05-08 | — | — | US | disclosed |
| WO-2014062697-A2 | DRUG DELIVERY CONJUGATES CONTAINING UNNATURAL AMINO ACIDS AND METHODS FOR USING | ENDOCYTE, INC. (US) | 2014-04-24 | — | — | WO | disclosed |
| US-20140112960-A1 | VISIBLE LIGHT CURABLE HYDROGELS AND METHODS FOR USING | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2014-04-24 | — | — | US | disclosed |
| US-20140107328-A1 | CHEMOSELECTIVE ENRICHMENT FOR COMPOUND ISOLATION | INDIANA UNIVERSITY RESEARCH & TECHNOLOGY CORPORATION | 2014-04-17 | — | — | US | disclosed |
| EP-2718255-A1 | QUINONE COMPOUNDS FOR TREATING APE1 MEDIATED DISEASES | Indiana University Research and Technology Corporation (US) | 2014-04-16 | — | — | EP | disclosed |
| CN-103703174-A | Combination pharmaceutical compositions and uses thereof | INTELLIKINE LLC | 2014-04-02 | — | — | CN | disclosed |
| US-20140080175-A1 | PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF | ENDOCYTE, INC. (US) | 2014-03-20 | — | — | US | disclosed |
| EP-2704723-A2 | TREATMENT OF POLYCYSTIC DISEASE | The Regents of the University of California (US) | 2014-03-12 | — | — | EP | disclosed |
| EP-2705181-A1 | COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | Intellikine, LLC (US) | 2014-03-12 | — | — | EP | disclosed |
| WO-2014036443-A2 | HETEROCYCLYL CARBOXAMIDES FOR TREATING VIRAL DISEASES | NOVADRUG, LLC (US) | 2014-03-06 | — | — | WO | disclosed |
| US-20140066462-A1 | TREATMENT OF POLYCYSTIC DISEASE | INTELLIKINE LLC (US) | 2014-03-06 | — | — | US | disclosed |
| US-8653268-B2 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI Pharmaceuticals, LLC (US) | 2014-02-18 | — | — | US | disclosed |
| US-20140031360-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2014-01-30 | — | — | US | disclosed |
| US-20140030256-A1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE LLC (US) | 2014-01-30 | — | — | US | disclosed |
| EP-2688566-A2 | ANTICANCER THERAPEUTIC AGENTS | Indiana University Research and Technology Corporation (US) | 2014-01-29 | — | — | EP | disclosed |
| US-8637542-B2 | Kinase inhibitors and methods of use | INTELLIKINE, INC. (US) | 2014-01-28 | — | — | US | disclosed |
| WO-2014015137-A2 | COMPOSITIONS AND METHODS FOR TREATING DYSPROLIFERATIVE DISEASES | ANGION BIOMEDICA CORP. (US) | 2014-01-23 | — | — | WO | disclosed |
| EP-2686394-A1 | SILICONE RELEASE COATING COMPOSITIONS | Dow Corning Corporation (US) | 2014-01-22 | — | — | EP | disclosed |
| US-20140018401-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP (US) | 2014-01-16 | — | — | US | disclosed |
| EP-2429290-B1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | PURDUE RESEARCH FOUNDATION (US) | 2014-01-01 | — | — | EP | disclosed |
| CN-103491962-A | Combinations of kinase inhibitors and uses thereof | INTELLIKINE LLC | 2014-01-01 | — | — | CN | disclosed |
| US-20130345231-A1 | ANTICANCER THERAPEUTIC AGENTS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-12-26 | — | — | US | disclosed |
| US-20130345424-A1 | COMPOSITIONS AND USES THEREOF TO AMELIORATE PAIN | PURDUE RESEARCH FOUNDATION (US) | 2013-12-26 | — | — | US | disclosed |
| US-20130338380-A1 | PROCESSES AND INTERMEDIATES FOR PREPARING SUBSTITUTED HEXAHYDROFURO [2,3-b] FURANS | PURDUE RESEARCH FOUNDATION (US) | 2013-12-19 | — | — | US | disclosed |
| US-20130338144-A1 | uPAR-uPA INTERACTION INHIBITORS AND METHODS FOR TREATING CANCER | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-12-19 | — | — | US | disclosed |
| US-8604205-B2 | Cytoskeletal active rho kinase inhibitor compounds, composition and use | INSPIRE PHARMACEUTICALS, INC. (US) | 2013-12-10 | — | — | US | disclosed |
| US-8604218-B2 | Cytoskeletal active rho kinase inhibitor compounds, composition and use | INSPIRE PHARMACEUTICALS, INC. (US) | 2013-12-10 | — | — | US | disclosed |
| WO-2013181592-A2 | PROCESS FOR PREPARING DIHALOPYRIDINES | VERTELLUS SPECIALTIES INC. (US) | 2013-12-05 | — | — | WO | disclosed |
| US-8575164-B2 | Combination cancer therapy | OSI Pharmaceuticals, LLC (US) | 2013-11-05 | — | — | US | disclosed |
| US-8575167-B2 | Spiro compounds having stearoyl-CoA desaturase action | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2013-11-05 | — | — | US | disclosed |
| WO-2013163562-A2 | COMPOSITIONS AND METHODS FOR TREATING PTSD AND RELATED DISEASES | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-10-31 | — | — | WO | disclosed |
| US-20130289067-A1 | COMPOUNDS AND METHODS FOR TREATING HIV | PURDUE RESEARCH FOUNDATION | 2013-10-31 | — | — | US | disclosed |
| US-20130281485-A1 | BRIDGED BICYCLIC RHO KINASE INHIBITOR COMPOUNDS, COMPOSITIONS AND USE | MERCK SHARP & DOHME LLC | 2013-10-24 | — | — | US | disclosed |
| US-8563597-B2 | Fused tricyclic ether carbamates and their use | PURDUE RESEARCH FOUNDATION (US) | 2013-10-22 | — | — | US | disclosed |
| EP-2649065-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | Amgen Inc. (US) | 2013-10-16 | — | — | EP | disclosed |
| WO-2013150123-A1 | BINDERS AND ASSOCIATED PRODUCTS | KNAUF INSULATION (BE) | 2013-10-10 | — | — | WO | disclosed |
| WO-2013149185-A1 | PROCESSES FOR PREPARING TUBULYSIN DERIVATIVES AND CONJUGATES THEREOF | ENDOCYTE, INC. (US) | 2013-10-03 | — | — | WO | disclosed |
| WO-2013148891-A1 | PARENTERAL FORMULATIONS FOR ADMINISTERING MACROLIDE ANTIBIOTICS | CEMPRA PHARMACEUTICALS, INC. (US) | 2013-10-03 | — | — | WO | disclosed |
| EP-2640191-A1 | 5-HALOGENOPYRAZOLE(THIO)CARBOXAMIDES | Bayer Intellectual Property GmbH (DE) | 2013-09-25 | — | — | EP | disclosed |
| WO-2013138430-A1 | COMPOUNDS AND METHODS FOR TREATING LEUKEMIA | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2013-09-19 | — | — | WO | disclosed |
| CN-101528653-B | Radiation-sensitive composition | MITSUBISHI GAS CHEMICAL CO | 2013-09-11 | — | — | CN | disclosed |
| CN-102325802-B | Method for producing fluoroolefin copolymer solution and method for producing paint composition | ASAHI GLASS CO LTD | 2013-09-11 | — | — | CN | disclosed |
| WO-2013130776-A1 | FOLATE RECEPTOR ALPHA BINDING LIGANDS | PURDUE RESEARCH FOUNDATION (US) | 2013-09-06 | — | — | WO | disclosed |
| US-20130231343-A1 | COMPOUNDS AND METHODS FOR TREATING MULTIPLE SCLEROSIS | PURDUE RESEARCH FOUNDATION (US) | 2013-09-05 | — | — | US | disclosed |
| US-20130231303-A1 | 5-HALOGENOPYRAZOLE(THIO)CARBOXAMIDES | BAYER INTELLECTUAL PROPERTY GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| CN-103259044-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP | 2013-08-21 | — | — | CN | disclosed |
| CN-103254172-A | Cytoskeletal active rho kinase inhibitor compounds, composition and use | INSPIRE PHARMACEUTICALS INC | 2013-08-21 | — | — | CN | disclosed |
| US-8513291-B2 | Cytochrome P450 inhibitors and uses thereof | ANGION BIOMEDICA CORP. (US) | 2013-08-20 | — | — | US | disclosed |
| US-20130209543-A1 | ENHANCED TREATMENT REGIMENS USING MTOR INHIBITORS | INTELLIKINE LLC (US) | 2013-08-15 | — | — | US | disclosed |
| CN-103249305-A | Method for treating ophthalmic diseases using kinase inhibitor compounds in prodrug forms | INSPIRE PHARMACEUTICALS INC | 2013-08-14 | — | — | CN | disclosed |
| US-20130190496-A1 | 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors | OSI Pharmaceuticals, LLC | 2013-07-25 | — | — | US | disclosed |
| EP-2617088-A2 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | Knauf Insulation GmbH (US) | 2013-07-24 | — | — | EP | disclosed |
| US-20130174758-A1 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION GMBH (US) | 2013-07-11 | — | — | US | disclosed |
| EP-2611295-A1 | FUSED TRICYCLIC ETHER CARBAMATES AND THEIR USE | Purdue Research Foundation (US) | 2013-07-10 | — | — | EP | disclosed |
| US-20130172324-A1 | METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. (US) | 2013-07-04 | — | — | US | disclosed |
| US-8476295-B2 | Bridged bicyclic RHO kinase inhibitor compounds, composition and use | Inspire (US) | 2013-07-02 | — | — | US | disclosed |
| US-8476282-B2 | Benzoxazole kinase inhibitors and methods of use | INTELLIKINE LLC (US) | 2013-07-02 | — | — | US | disclosed |
| US-8476431-B2 | Benzoxazole kinase inhibitors and methods of use | Itellikine LLC (US) | 2013-07-02 | — | — | US | disclosed |
| CN-103172657-A | Alkynyl-containing functionalized cage-type polyhedral polysilsesquioxane and preparation method thereof | UNIV BEIJING CHEMICAL | 2013-06-26 | — | — | CN | disclosed |
| US-20130158094-A1 | FUSED TRICYCLIC ETHER CARBAMATES AND THEIR USE | PURDUE RESEARCH FOUNDATION (US) | 2013-06-20 | — | — | US | disclosed |
| US-20130158014-A1 | METHOD FOR TREATING DISEASES ASSOCIATED WITH ALTERATIONS IN CELLULAR INTEGRITY USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. (US) | 2013-06-20 | — | — | US | disclosed |
| WO-2013085824-A1 | SMALL MOLECULE ANTI-FIBROTIC COMPOUNDS AND USES THEREOF | ANGION BIOMEDICA CORP. (US) | 2013-06-13 | — | — | WO | disclosed |
| EP-2600866-A1 | PROCESSES FOR PREPARING TUBULYSINS | Endocyte, Inc. (US) | 2013-06-12 | — | — | EP | disclosed |
| US-20130143878-A1 | SUBSTITUTED DIBENZONAPHTHYRIDINES, PHARMACEUTICAL USES THEREOF AND PROCESSES THERFOR | PURDUE RESEARCH FOUNDATION (US) | 2013-06-06 | — | — | US | disclosed |
| EP-2597953-A1 | METHOD FOR TREATING OPHTHALMIC DISEASES USING KINASE INHIBITOR COMPOUNDS IN PRODRUG FORMS | Inspire Pharmaceuticals, Inc. (US) | 2013-06-05 | — | — | EP | disclosed |
| US-20130137139-A1 | PROCESSES FOR PREPARING TUBULYSINS | ENDOCYTE, INC. (US) | 2013-05-30 | — | — | US | disclosed |
| WO-2013078440-A2 | ENHANCED TREATMENT REGIMENS USING MTOR INHIBITORS | INTELLIKINE, LLC (US) | 2013-05-30 | — | — | WO | disclosed |
| EP-2595665-A1 | BIFUNCTIONAL RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | Inspire Pharmaceuticals, Inc. (US) | 2013-05-29 | — | — | EP | disclosed |
| US-8450329-B2 | — | — | 2013-05-28 | — | — | US | disclosed |
| US-8450480-B2 | — | — | 2013-05-28 | — | — | US | disclosed |
| US-20130131106-A1 | BIFUNCTIONAL RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | INSPIRE PHARMACEUTICALS, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| US-20130131059-A1 | METHOD FOR TREATING OPHTHALMIC DISEASES USING KINASE INHIBITOR COMPOUNDS IN PRODRUG FORMS | INSPIRE PHARMACEUTICALS, INC. (US) | 2013-05-23 | — | — | US | disclosed |
| WO-2013071264-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013070976-A1 | TREATMENT REGIMENS USING MULTIPLE PHARMACEUTICAL AGENTS | INTELLIKINE, LLC (US) | 2013-05-16 | — | — | WO | disclosed |
| CN-103102251-A | Radiation-sensitive composition | MITSUBISHI GAS CHEMICAL CO | 2013-05-15 | — | — | CN | disclosed |
| EP-2587919-A1 | METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER | Azevan Pharmaceuticals, Inc. (US) | 2013-05-08 | — | — | EP | disclosed |
| CN-103097925-A | Diffractive optical element and measurement device | ASAHI GLASS CO LTD | 2013-05-08 | — | — | CN | disclosed |
| US-20130109666-A1 | METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER | AZEVAN PHARMACEUTICALS, INC. (US) | 2013-05-02 | — | — | US | disclosed |
| US-20130102643-A1 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP | 2013-04-25 | — | — | US | disclosed |
| CN-103052406-A | Bifunctional rho kinase inhibitor compounds, compositions and uses | INSPIRE PHARMACEUTICALS INC | 2013-04-17 | — | — | CN | disclosed |
| EP-2576544-A2 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | Angion Biomedica Corp. (US) | 2013-04-10 | — | — | EP | disclosed |
| WO-2013045259-A1 | PROCESS FOR PREPARING AN AQUEOUS POLYMER DISPERSION | BASF SE (DE) | 2013-04-04 | — | — | WO | disclosed |
| US-8410147-B2 | Method for treating diseases associated with alterations in cellular integrity using Rho kinase inhibitor compounds | INSPIRE PHARMACEUTICALS, INC. (US) | 2013-04-02 | — | — | US | disclosed |
| CN-102985420-A | Cytochrome P450 inhibitors and uses thereof | ANGION BIOMEDICA CORP | 2013-03-20 | — | — | CN | disclosed |
| EP-2566903-A1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | Knauf Insulation (BE) | 2013-03-13 | — | — | EP | disclosed |
| EP-2566904-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | Knauf Insulation (BE) | 2013-03-13 | — | — | EP | disclosed |
| EP-2566497-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | Codexis, Inc. (US) | 2013-03-13 | — | — | EP | disclosed |
| US-20130059075-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION (BE) | 2013-03-07 | — | — | US | disclosed |
| US-20130059881-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | NOVADRUG, LLC (US) | 2013-03-07 | — | — | US | disclosed |
| US-20130052699-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | CODEXIS, INC. (US) | 2013-02-28 | — | — | US | disclosed |
| US-20130047888-A1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION (BE) | 2013-02-28 | — | — | US | disclosed |
| WO-2013028890-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | NOVADRUG, LLC (US) | 2013-02-28 | — | — | WO | disclosed |
| US-20130045937-A1 | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS | CEMPRA PHARMACEUTICALS, INC. (US) | 2013-02-21 | — | — | US | disclosed |
| US-20130041106-A1 | CHEMOSELECTIVE ENRICHMENT FOR COMPOUND ISOLATION | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-02-14 | — | — | US | disclosed |
| CN-102924458-A | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI PHARM INC | 2013-02-13 | — | — | CN | disclosed |
| WO-2013019967-A1 | MODULATORS OF VIRUS ASSEMBLY AS ANTIVIRAL AGENTS | SCRIPPS RESEARCH INSTITUTE, A NOT-FOR-PROFIT PUBLIC BENEFIT CORPORATION OF CALIFORNIA (US) | 2013-02-07 | — | — | WO | disclosed |
| US-8367826-B2 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI Pharmaceuticals, LLC (US) | 2013-02-05 | — | — | US | disclosed |
| CN-101583361-B | Cytoskeletal Active RHO Kinase Inhibitor Compounds, Compositions and Uses | INSPIRE PHARMACEUTICALS INC | 2013-01-23 | — | — | CN | disclosed |
| WO-2013009844-A2 | C-3 SUBSTITUTED BICYCLOOCTANE BASED HIV PROTEASE INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2013-01-17 | — | — | WO | disclosed |
| EP-2544537-A1 | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS | Cempra Pharmaceuticals, Inc. (US) | 2013-01-16 | — | — | EP | disclosed |
| US-20130012543-A1 | CYTOSKELETAL ACTIVE RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | MERCK SHARP & DOHME LLC | 2013-01-10 | — | — | US | disclosed |
| EP-2542240-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | Novadrug, LLC (US) | 2013-01-09 | — | — | EP | disclosed |
| US-20130005756-A1 | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | NAVRATIL TOMAS (US) | 2013-01-03 | — | — | US | disclosed |
| WO-2012173677-A2 | ANTICANCER THERAPEUTIC AGENTS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-12-20 | — | — | WO | disclosed |
| WO-2012167122-A1 | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-12-06 | — | — | WO | disclosed |
| EP-2528440-A1 | SUBSTITUTED NORINDENOISOQUINOLINES, SYNTHESES THEREOF, AND METHODS OF USE | Purdue Research Foundation (US) | 2012-12-05 | — | — | EP | disclosed |
| US-20120302563-A1 | SUBSTITUTED NORINDENOISOQUINOLINES, SYNTHESES THEREOF, AND METHODS OF USE | PURDUE RESEARCH FOUNDATION (US) | 2012-11-29 | — | — | US | disclosed |
| WO-2012162589-A1 | QUINONE COMPOUNDS FOR TREATING APE1 MEDIATED DISEASES | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-11-29 | — | — | WO | disclosed |
| WO-2012162513-A2 | ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS | PURDUE RESEARCH FOUNDATION (US) | 2012-11-29 | — | — | WO | disclosed |
| US-20120294930-A1 | COMBINATION OF KINASE INHIBITORS AND USES THEREOF | INTELLIKINE LLC (US) | 2012-11-22 | — | — | US | disclosed |
| WO-2012154610-A1 | REACTIVE PI3K KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2012-11-15 | — | — | WO | disclosed |
| WO-2012154695-A2 | TREATMENT OF POLYCYSTIC DISEASE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-11-15 | — | — | WO | disclosed |
| WO-2012154608-A1 | REACTIVE MTOR AND PI3 KINASE INHIBITORS AND USES THEREOF | INTELLIKINE, LLC (US) | 2012-11-15 | — | — | WO | disclosed |
| WO-2012151562-A1 | COMBINATION PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | INTELLIKINE, LLC (US) | 2012-11-08 | — | — | WO | disclosed |
| US-20120279570-A1 | SOLUBLE GRAPHENE NANOSTRUCTURES AND ASSEMBLIES THEREFROM | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-11-08 | — | — | US | disclosed |
| WO-2012148540-A1 | COMBINATION OF KANASE INHIBITORS AND USES THREOF | INTELLIKINE, LLC (US) | 2012-11-01 | — | — | WO | disclosed |
| CN-101356173-B | Novel pyridopyrazines and their use as modulators of kinases | AETERNA ZENTARIS GMBH | 2012-10-31 | — | — | CN | disclosed |
| US-8299096-B2 | Method for treating pulmonary diseases using rho kinase inhibitor compounds | INSPIRE PHARMACEUTICALS, INC. (US) | 2012-10-30 | — | — | US | disclosed |
| EP-2512239-A1 | BRIDGED BICYCLIC RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | Inspire Pharmaceuticals, Inc. (US) | 2012-10-24 | — | — | EP | disclosed |
| EP-1957496-B1 | BICYCLIC PROTEIN KINASE INHIBITORS | OSI PHARM INC (US) | 2012-10-24 | — | — | EP | disclosed |
| US-8278820-B2 | Active matrix organic electroluminescent device and method of manufacture thereof | University of Electric Sience and Technology of China (CN) | 2012-10-02 | — | — | US | disclosed |
| WO-2012128919-A1 | SILICONE RELEASE COATING COMPOSITIONS | DOW CORNING CORPORATION (US) | 2012-09-27 | — | — | WO | disclosed |
| WO-2012125009-A2 | CHEMICALLY AMPLIFIED POSITIVE PHOTOSENSITIVE COMPOSITION FOR AN ORGANIC INSULATION FILM, AND METHOD FOR FORMING AN ORGANIC INSULATION FILM USING SAME | LEE YUN HYEONG (KR) | 2012-09-20 | — | — | WO | disclosed |
| WO-2012119079-A1 | uPAR-uPA INTERACTION INHIBITORS AND METHODS FOR TREATING CANCER | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-09-07 | — | — | WO | disclosed |
| WO-2012119045-A2 | COMPOSITIONS AND USES THEREOF TO AMELIORATE PAIN | PURDUE RESEARCH FOUNDATION (US) | 2012-09-07 | — | — | WO | disclosed |
| WO-2012109573-A1 | SUBSTITUTED THIAZOLES FOR USE AS ANTIVIRAL AGENTS | PURDUE RESEARCH FOUNDATION (US) | 2012-08-16 | — | — | WO | disclosed |
| US-20120196847-A1 | 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors | OSI Pharmaceuticals, LLC | 2012-08-02 | — | — | US | disclosed |
| WO-2012103444-A2 | IMMUNOGENIC COMPOSITIONS AND REAGENTS FOR PREPARING | PURDUE RESEARCH FOUNDATION (US) | 2012-08-02 | — | — | WO | disclosed |
| EP-2475253-A1 | METHODS FOR TREATING MALARIA, TUBERCULOSIS AND MAC DISEASES | Cempra Pharmaceuticals, Inc. (US) | 2012-07-18 | — | — | EP | disclosed |
| WO-2012092168-A1 | FUSED 6,5 BICYCLIC RING SYSTEM P2 LIGANDS, AND METHODS FOR TREATING HIV | PURDUE RESEARCH FOUNDATION (US) | 2012-07-05 | — | — | WO | disclosed |
| US-20120172323-A1 | METHODS FOR TREATING MALARIA, TUBERCULOSIS AND MAC DISEASES | CEMPRA PHARMACEUTICALS, INC. (US) | 2012-07-05 | — | — | US | disclosed |
| WO-2012092188-A1 | HYDROGEN BOND FORMING P1 LIGANDS AND METHODS FOR TREATING HIV | GHOSH ARUN K (US) | 2012-07-05 | — | — | WO | disclosed |
| US-20120164762-A1 | Active matrix organic electroluminescent device and method of manufacture thereof | UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA | 2012-06-28 | — | — | US | disclosed |
| CN-101595096-B | Substituted carbinol compounds | KOWA CO JP | 2012-06-27 | — | — | CN | disclosed |
| US-8207195-B2 | Method for treating neurological and neuropathic diseases using rho kinase inhibitor compounds | INSPIRE PHARMACEUTICALS, INC. (US) | 2012-06-26 | — | — | US | disclosed |
| WO-2012083181-A1 | ALPHA HELIX MIMETICS AND METHODS FOR USING | INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION (US) | 2012-06-21 | — | — | WO | disclosed |
| WO-2012078777-A1 | BICYCLIC COMPOUNDS AS PIM INHIBITORS | AMGEN INC. (US) | 2012-06-14 | — | — | WO | disclosed |
| WO-2012075122-A2 | PROCESSES AND INTERMEDIATES FOR PREPARING SUBSTITUTED HEXAHYDROFURO [2,3-B] FURANS | PURDUE RESEARCH FOUNDATION (US) | 2012-06-07 | — | — | WO | disclosed |
| WO-2012065945-A1 | 5-HALOGENOPYRAZOLE(THIO)CARBOXAMIDES | BAYER CROPSCIENCE AG (DE) | 2012-05-24 | — | — | WO | disclosed |
| WO-2012064923-A2 | COMPOUNDS AND METHODS FOR TREATING MULTIPLE SCLEROSIS | PURDUE RESEARCH FOUNDATION (US) | 2012-05-18 | — | — | WO | disclosed |
| US-8178668-B2 | 2-aminopyridine kinase inhibitors | OSI Pharmaceuticals, LLC (US) | 2012-05-15 | — | — | US | disclosed |
| US-8168666-B2 | Substituted carbinol compound | KOWA COMPANY, LTD. (JP) | 2012-05-01 | — | — | US | disclosed |
| CN-101432923-B | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP | 2012-04-18 | — | — | CN | disclosed |
| US-8158796-B2 | Process for the preparation of Rho-kinase inhibitor compounds | INSPIRE PHARMACEUTICALS, INC. (US) | 2012-04-17 | — | — | US | disclosed |
| US-20120077979-A1 | 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors | OSI Pharmaceuticals, LLC | 2012-03-29 | — | — | US | disclosed |
| WO-2012037451-A2 | ORGANIC ACID CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION GMBH (US) | 2012-03-22 | — | — | WO | disclosed |
| EP-2429290-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | Purdue Research Foundation (US) | 2012-03-21 | — | — | EP | disclosed |
| WO-2012031237-A1 | FUSED TRICYCLIC ETHER CARBAMATES AND THEIR USE | PURDUE RESEARCH FOUNDATION (US) | 2012-03-08 | — | — | WO | disclosed |
| US-20120059161-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | PURDUE RESEARCH FOUNDATION (US) | 2012-03-08 | — | — | US | disclosed |
| WO-2012024437-A1 | SUBSTITUTED DIBENZONAPHTHYRIDINES, PHARMACEUTICAL USES THEREOF AND PROCESSES THERFOR | PURDUE RESEARCH FOUNDATION (US) | 2012-02-23 | — | — | WO | disclosed |
| US-20120046275-A1 | CYTOSKELETAL ACTIVE RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | MERCK SHARP & DOHME LLC | 2012-02-23 | — | — | US | disclosed |
| WO-2012019123-A1 | PROCESSES FOR PREPARING TUBULYSINS | ENDOCYTE, INC. (US) | 2012-02-09 | — | — | WO | disclosed |
| EP-2098515-B1 | SUBSTITUTED CARBINOL COMPOUND | KOWA CO (JP) | 2012-02-08 | — | — | EP | disclosed |
| WO-2012015760-A1 | METHOD FOR TREATING OPHTHALMIC DISEASES USING KINASE INHIBITOR COMPOUNDS IN PRODRUG FORMS | INSPIRE PHARMACEUTICALS, INC. (US) | 2012-02-02 | — | — | WO | disclosed |
| WO-2012012282-A1 | BIFUNCTIONAL RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | INSPIRE PHARMACEUTICALS, INC. (US) | 2012-01-26 | — | — | WO | disclosed |
| US-8101613-B2 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI Pharmaceuticals, LLC (US) | 2012-01-24 | — | — | US | disclosed |
| CN-102325802-A | Method for producing fluoroolefin copolymer solution and method for producing paint composition | ASAHI GLASS CO LTD | 2012-01-18 | — | — | CN | disclosed |
| WO-2012003436-A1 | METHODS FOR TREATING POST TRAUMATIC STRESS DISORDER | AZEVAN PHARMACEUTICALS, INC. (US) | 2012-01-05 | — | — | WO | disclosed |
| EP-2400969-A1 | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | Inspire Pharmaceuticals, Inc. (US) | 2012-01-04 | — | — | EP | disclosed |
| WO-2011153192-A2 | CYTOCHROME P450 INHIBITORS AND USES THEREOF | ANGION BIOMEDICA CORP. (US) | 2011-12-08 | — | — | WO | disclosed |
| CN-102271513-A | Benzoxazole kinase inhibitors and methods of use | — | 2011-12-07 | — | — | CN | disclosed |
| US-8071779-B2 | reduces intraocular pressure; primary open-angle glaucoma; effective to influence the actomyosin interactions by leading to cellular relaxation and alterations in cell-substratum adhesions | INSPIRE PHARMACEUTICALS, INC. (US) | 2011-12-06 | — | — | US | disclosed |
| WO-2011138459-A1 | CARBOHYDRATE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION (BE) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011140219-A1 | BIOCATALYSTS FOR EZETIMIBE SYNTHESIS | CODEXIS, INC. (US) | 2011-11-10 | — | — | WO | disclosed |
| WO-2011138458-A1 | CARBOHYDRATE POLYAMINE BINDERS AND MATERIALS MADE THEREWITH | KNAUF INSULATION (BE) | 2011-11-10 | — | — | WO | disclosed |
| EP-2365750-A1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | Intellikine, Inc. (US) | 2011-09-21 | — | — | EP | disclosed |
| WO-2011112864-A1 | PARENTERAL FORMULATIONS OF MACROLIDE ANTIBIOTICS | CEMPRA PHARMACEUTICALS, INC. (US) | 2011-09-15 | — | — | WO | disclosed |
| US-20110221331-A1 | Active matrix organic electroluminescent device and method of manufacture thereof | UNIVERSITY OF ELECTRONIC SCIENCE AND TECHNOLOGY OF CHINA | 2011-09-15 | — | — | US | disclosed |
| WO-2011109232-A1 | COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES | NOVADRUG, LLC (US) | 2011-09-09 | — | — | WO | disclosed |
| US-8003627-B2 | Urokinase inhibitors | UNIVERSITEIT ANTWERPEN (BE) | 2011-08-23 | — | — | US | disclosed |
| WO-2011094416-A1 | SUBSTITUTED NORINDENOISOQUINOLINES, SYNTHESES THEREOF, AND METHODS OF USE | PURDUE RESEARCH FOUNDATION (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011085185-A1 | SOLUBLE GRAPHENE NANOSTRUCTURES AND ASSEMBLIES THEREFROM | LI LIANG-SHI (US) | 2011-07-14 | — | — | WO | disclosed |
| WO-2011075415-A1 | BRIDGED BICYCLIC RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | INSPIRE PHARMACEUTICALS, INC. (US) | 2011-06-23 | — | — | WO | disclosed |
| US-20110144150-A1 | BRIDGED BICYCLIC RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | MERCK SHARP & DOHME LLC | 2011-06-16 | — | — | US | disclosed |
| CN-102097654-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP | 2011-06-15 | — | — | CN | disclosed |
| US-20110124641-A1 | BENZOTHIAZOLE KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE LLC | 2011-05-26 | — | — | US | disclosed |
| CN-102065689-A | RHO-kinase inhibitor compounds | INSPIRE PHARMACEUTICALS INC | 2011-05-18 | — | — | CN | disclosed |
| EP-2317849-A1 | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | Inspire Pharmaceuticals, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| EP-2308879-A1 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI Pharmaceuticals, Inc. (US) | 2011-04-13 | — | — | EP | disclosed |
| EP-2305682-A1 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI Pharmaceuticals, Inc. (US) | 2011-04-06 | — | — | EP | disclosed |
| US-20110077268-A1 | KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE LLC | 2011-03-31 | — | — | US | disclosed |
| EP-2299820-A1 | OPHTHALMIC FORMULATION OF RHO KINASE INHIBITOR COMPOUND | Inspire Pharmaceuticals, Inc. (US) | 2011-03-30 | — | — | EP | disclosed |
| WO-2011032052-A1 | METHODS FOR TREATING MALARIA, TUBERCULOSIS AND MAC DISEASES | CEMPRA PHARMACEUTICALS, INC. (US) | 2011-03-17 | — | — | WO | disclosed |
| EP-2291077-A1 | PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS | Inspire Pharmaceuticals, Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| US-20110046144-A1 | IMIDAZOPYRAZINOL DERIVATIVES FOR THE TREATMENT OF CANCERS | OSI PHARMACEUTICALS, INC. | 2011-02-24 | — | — | US | disclosed |
| EP-2265270-A1 | 2-AMINOPYRIDINE KINASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2010-12-29 | — | — | EP | disclosed |
| EP-2252293-A2 | KINASE INHIBITORS AND METHODS OF USE | Intellikine, Inc. (US) | 2010-11-24 | — | — | EP | disclosed |
| WO-2010132494-A1 | COMPOUNDS AND METHODS FOR TREATING AIDS AND HIV INFECTIONS | GHOSH ARUN K (US) | 2010-11-18 | — | — | WO | disclosed |
| EP-2250173-A1 | IMIDAZOPYRAZINOL DERIVATIVES FOR THE TREATMENT OF CANCERS | OSI Pharmaceuticals, Inc. (US) | 2010-11-17 | — | — | EP | disclosed |
| CN-1819996-B | Naphthylene derivatives as cytochrome P450 inhibitors | OSI PHARM INC | 2010-10-27 | — | — | CN | disclosed |
| US-7820662-B2 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI PHARMACEUTICALS, INC. (US) | 2010-10-26 | — | — | US | disclosed |
| US-20100204210-A1 | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2010-08-12 | — | — | US | disclosed |
| US-20100190749-A1 | Benzoxazole kinase inhibitors and methods of use | FAETH THERAPEUTICS, INC. | 2010-07-29 | — | — | US | disclosed |
| US-20100184760-A1 | Benzoxazole kinase inhibitors and methods of use | FAETH THERAPEUTICS, INC. | 2010-07-22 | — | — | US | disclosed |
| US-7741324-B2 | Imidazotriazines as protein kinase inhibitors | OSI PHARMACEUTICALS, INC. (US) | 2010-06-22 | — | — | US | disclosed |
| WO-2010065782-A1 | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. (US) | 2010-06-10 | — | — | WO | disclosed |
| CN-1762957-B | 2,3-dihydro-1-indene compound and preparation method thereof | BASELL POLYOLEFINE GMBH | 2010-05-12 | — | — | CN | disclosed |
| WO-2010051043-A1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| WO-2010051042-A1 | BENZOXAZOLE KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE, INC. (US) | 2010-05-06 | — | — | WO | disclosed |
| EP-2168968-A1 | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI Pharmaceuticals, Inc. (US) | 2010-03-31 | — | — | EP | disclosed |
| US-20100069351-A1 | SPIRO COMPOUND AND USE THEREOF | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2010-03-18 | — | — | US | disclosed |
| US-20100063119-A1 | SUBSTITUTED CARBINOL COMPOUND | KOWA COMPANY, LTD. (JP) | 2010-03-11 | — | — | US | disclosed |
| US-7662844-B2 | Naphthylene derivatives as cytochrome P450 inhibitors | OSI PHARMACEUTICALS, INC. (US) | 2010-02-16 | — | — | US | disclosed |
| US-20100029724-A1 | SCREENING METHOD | TAKEDA PHARMACEUTICAL COMPANY LIMITED | 2010-02-04 | — | — | US | disclosed |
| EP-2149457-A2 | Inkjet recording method, inkjet recording system, and printed material | Fujifilm Corporation (JP) | 2010-02-03 | — | — | EP | disclosed |
| US-20100022775-A1 | PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2010-01-28 | — | — | US | disclosed |
| US-20100022517-A1 | OPHTHALMIC FORMULATION OF RHO KINASE INHIBITOR COMPOUND | INSPIRE PHARMACEUTICALS, INC. | 2010-01-28 | — | — | US | disclosed |
| EP-2045301-B1 | Composition for fluoresin powder coating material | ASAHI GLASS CO LTD (JP) | 2010-01-20 | — | — | EP | disclosed |
| US-7648987-B2 | Bicyclic protein kinase inhibitors | OSI PHARMACEUTICALS, INC. (US) | 2010-01-19 | — | — | US | disclosed |
| US-20100008968-A1 | METHOD FOR TREATING CARDIOVASCULAR DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2010-01-14 | — | — | US | disclosed |
| US-20090325934-A1 | METHOD FOR TREATING NEUROLOGICAL AND NEUROPATHIC DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090325958-A1 | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090325905-A1 | METHOD FOR TREATING DISEASES ASSOCIATED WITH ALTERATIONS IN CELLULAR INTEGRITY USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090325960-A1 | METHOD FOR TREATING INFLAMMATORY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090325928-A1 | 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors | OSI PHARMACEUTICALS, INC. | 2009-12-31 | — | — | US | disclosed |
| US-20090325959-A1 | METHOD FOR TREATING OPHTHALMIC DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. | 2009-12-31 | — | — | US | disclosed |
| WO-2009158587-A1 | METHOD FOR TREATING PULMONARY DISEASES USING RHO KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. (US) | 2009-12-30 | — | — | WO | disclosed |
| CN-100575409-C | Laminate hose with the fluorinated copolymer manufacturing | ASAHI GLASS CO LTD | 2009-12-30 | — | — | CN | disclosed |
| WO-2009155209-A1 | OPHTHALMIC FORMULATION OF RHO KINASE INHIBITOR COMPOUND | INSPIRE PHARMACEUTICALS, INC. (US) | 2009-12-23 | — | — | WO | disclosed |
| WO-2009154940-A1 | PROCESS FOR THE PREPARATION OF RHO-KINASE INHIBITOR COMPOUNDS | INSPIRE PHARMACEUTICALS, INC. (US) | 2009-12-23 | — | — | WO | disclosed |
| EP-2131836-A1 | COMBINATION OF IMIDAZO Ý1,5-A¨PYRAZINYL DERIVATIVES WITH AN AGENT THAT INHIBITS SERINE PHOSPHORYLATION OF IRS1 FOR USE IN THE TREATMENT OF CANCER | OSI Pharmaceuticals, Inc. (US) | 2009-12-16 | — | — | EP | disclosed |
| CN-101595096-A | Substituted carbinol compounds | KOWA CO (JP) | 2009-12-02 | — | — | CN | disclosed |
| CN-101583361-A | Cytoskeletal Active RHO Kinase Inhibitor Compounds, Compositions and Uses | INSPIRE PHARMACEUTICALS INC (US) | 2009-11-18 | — | — | CN | disclosed |
| EP-1465010-B1 | Positive resist composition | FUJIFILM CORP (JP) | 2009-10-21 | — | — | EP | disclosed |
| WO-2009114870-A2 | KINASE INHIBITORS AND METHODS OF USE | INTELLIKINE, INC. (US) | 2009-09-17 | — | — | WO | disclosed |
| EP-2099457-A2 | CYTOSKELETAL ACTIVE RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | Inspire Pharmaceuticals, Inc. (US) | 2009-09-16 | — | — | EP | disclosed |
| EP-2098515-A1 | SUBSTITUTED CARBINOL COMPOUND | Kowa Company. Ltd. (JP) | 2009-09-09 | — | — | EP | disclosed |
| CN-100537688-C | Coating composition | DAIKIN IND LTD (JP) | 2009-09-09 | — | — | CN | disclosed |
| WO-2009099982-A1 | 2-AMINOPYRIDINE KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2009-08-13 | — | — | WO | disclosed |
| US-20090197862-A1 | 2-AMINOPYRIDINE KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. | 2009-08-06 | — | — | US | disclosed |
| CN-100522558-C | Fluorine copolymer | ASAHI GLASS CO LTD (JP) | 2009-08-05 | — | — | CN | disclosed |
| US-7566721-B2 | Substituted thienol[2,3-d]pyrimidines as kinase inhibitors | OSI PHARMACEUTICALS, INC. (US) | 2009-07-28 | — | — | US | disclosed |
| WO-2009091939-A1 | IMIDAZOPYRAZINOL DERIVATIVES FOR THE TREATMENT OF CANCERS | OSI PHARMACEUTICALS, INC. (US) | 2009-07-23 | — | — | WO | disclosed |
| US-20090181940-A1 | Imidazopyrazine Tyrosine Kinase Inhibitors | OSI PHARMACEUTICALS, INC. | 2009-07-16 | — | — | US | disclosed |
| WO-2009084737-A1 | COMPOUND HAVING ACTIVITY TO SUPPRESS DEGRANULATION AND CYTOKINE PRODUCTION AND USE THEREOF | INTERPROTEIN CORPORATION (JP) | 2009-07-09 | — | — | WO | disclosed |
| EP-1740591-B1 | 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS | OSI PHARM INC (US) | 2009-06-17 | — | — | EP | disclosed |
| US-7534797-B2 | 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors | OSI PHARMACEUTICALS, INC. (US) | 2009-05-19 | — | — | US | disclosed |
| CN-101432923-A | Nonaqueous electrolyte solution and nonaqueous electrolyte secondary battery | MITSUBISHI CHEM CORP (JP) | 2009-05-13 | — | — | CN | disclosed |
| US-20090118499-A1 | 6,6-Bicyclic Ring Substituted Heterobicyclic Protein Kinase Inhibitors | OSI PHARMACEUTICALS, INC. | 2009-05-07 | — | — | US | disclosed |
| EP-2051982-A1 | 6,6-BICYCLIC RING SUBSTITUTED SULFUR CONTAINING HETEROBICYCLIC PROTEIN KINASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2009-04-29 | — | — | EP | disclosed |
| EP-2045301-A1 | Composition for fluoresin powder coating material | Asahi Glass Company, Limited (JP) | 2009-04-08 | — | — | EP | disclosed |
| EP-2039779-A1 | SCREENING METHOD | Takeda Pharmaceutical Company Limited (JP) | 2009-03-25 | — | — | EP | disclosed |
| CN-101356173-A | Novel pyridopyrazines and their use as modulators of kinases | AETERNA ZENTARIS GMBH (DE) | 2009-01-28 | — | — | CN | disclosed |
| CN-100451024-C | Metallocene compound, indene compound and application thereof | BASELL POLYOLEFINE GMBH (DE) | 2009-01-14 | — | — | CN | disclosed |
| US-20080312191-A1 | Novel Urokinase Inhibitors | UNIVERSITEIT ANTWERPEN (BE) | 2008-12-18 | — | — | US | disclosed |
| US-7459554-B2 | Imidazopyrazine tyrosine kinase inhibitors | OSI PHARMACEUTICALS, INC. (US) | 2008-12-02 | — | — | US | disclosed |
| US-20080287438-A1 | Agent for preventing or treating neuropathy | MOMOSE YU | 2008-11-20 | — | — | US | disclosed |
| CN-100434472-C | Resin composition for color filter protective film and color filter | NIPPON OILS & FATS CO LTD (JP) | 2008-11-19 | — | — | CN | disclosed |
| US-20080267957-A1 | Combination cancer therapy | OSI PHARMACEUTICALS, INC. | 2008-10-30 | — | — | US | disclosed |
| EP-1979353-A2 | FUSED HETEROBICYCLIC KINASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2008-10-15 | — | — | EP | disclosed |
| US-20080227788-A9 | IMIDAZOPYRAZINE TYROSINE KINASE INHIBITORS | BECK PATRICIA A | 2008-09-18 | — | — | US | disclosed |
| US-7423159-B2 | Agent for preventing or treating neuropathy | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2008-09-09 | — | — | US | disclosed |
| US-20080214614-A1 | CYTOSKELETAL ACTIVE RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | MERCK SHARP & DOHME LLC | 2008-09-04 | — | — | US | disclosed |
| WO-2008106168-A1 | COMBINATION OF IMIDAZO [1,5-A] PYRAZINYL DERIVATIVES WITH AN AGENT THAT INHIBITS SERINE PHOSPHORYLATION OF IRS1 FOR USE IN THE TREATMENT OF CANCER | OSI PHARMACEUTICALS, INC. (US) | 2008-09-04 | — | — | WO | disclosed |
| EP-1957496-A2 | BICYCLIC PROTEIN KINASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2008-08-20 | — | — | EP | disclosed |
| EP-1942728-A1 | AGROCHEMICAL NANOPARTICULATE ACTIVE INGREDIENT FORMULATIONS | BASF SE (DE) | 2008-07-16 | — | — | EP | disclosed |
| EP-1942727-A1 | NANOPARTICULATE ACTIVE INGREDIENT FORMULATIONS | BASF SE (DE) | 2008-07-16 | — | — | EP | disclosed |
| EP-1940856-A1 | NOVEL UROKINASE INHIBITORS | Universiteit Antwerpen (BE) | 2008-07-09 | — | — | EP | disclosed |
| WO-2008077057-A2 | CYTOSKELETAL ACTIVE RHO KINASE INHIBITOR COMPOUNDS, COMPOSITION AND USE | INSPIRE PHARMACEUTICALS, INC. (US) | 2008-06-26 | — | — | WO | disclosed |
| WO-2008018881-A1 | 6,6-BICYCLIC RING SUBSTITUTED SULFUR CONTAINING HETEROBICYCLIC PROTEIN KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2008-02-14 | — | — | WO | disclosed |
| CN-101084218-A | Imidazotriazines as protein kinase inhibitors | OSI PHARM INC (US) | 2007-12-05 | — | — | CN | disclosed |
| EP-1853327-A2 | MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH COPOLYMERS CONTAINING HYDROCARBON AND HETEROATOM-CONTAINING MONOMERIC SPECIES | Boston Scientific Limited (BB) | 2007-11-14 | — | — | EP | disclosed |
| US-20070208053-A1 | Fused heterobicyclic kinase inhibitors | OSI PHARMACEUTICALS, INC. | 2007-09-06 | — | — | US | disclosed |
| EP-1730116-B1 | 4-CARBOX PYRAZOLE DERIVATES USEFUL AS ANTI-VIRAL AGENTS | SMITHKLINE BEECHAM CORP (US) | 2007-09-05 | — | — | EP | disclosed |
| WO-2007093232-A1 | AGROCHEMICAL NANOPARTICULATE ACTIVE INGREDIENT FORMULATIONS | BASF SE (DE) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007084667-A2 | FUSED HETEROBICYCLIC KINASE INHIBITORS | OSI PHARMACEUTICAL, INC. (US) | 2007-07-26 | — | — | WO | disclosed |
| US-20070149521-A1 | Bicyclic protein kinase inhibitors | OSI PHARMACEUTICALS, INC. | 2007-06-28 | — | — | US | disclosed |
| WO-2007064993-A2 | BICYCLIC PROTEIN KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2007-06-07 | — | — | WO | disclosed |
| EP-1781660-A1 | IMIDAZOPYRAZINE AS TYROSINE KINASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2007-05-09 | — | — | EP | disclosed |
| CN-1960993-A | 6, 6-bicyclic substituted heterobicyclic protein kinase inhibitors | OSI PHARM INC (US) | 2007-05-09 | — | — | CN | disclosed |
| WO-2007048730-A1 | NANOPARTICULATE ACTIVE INGREDIENT FORMULATIONS | BASF SE (DE) | 2007-05-03 | — | — | WO | disclosed |
| WO-2007045496-A1 | NOVEL UROKINASE INHIBITORS | UNIVERSITEIT ANTWERPEN (BE) | 2007-04-26 | — | — | WO | disclosed |
| US-7183276-B2 | Azole compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2007-02-27 | — | — | US | disclosed |
| US-20070032512-A1 | 6,6-Bicyclic ring substituted sulfur containing heterobicyclic protein kinase inhibitors | OSI PHARMACEUTICALS, INC., | 2007-02-08 | — | — | US | disclosed |
| EP-1740591-A1 | 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2007-01-10 | — | — | EP | disclosed |
| CN-1294217-C | Soluble fluorine-containing paint resin and method for preparing same | SHANGHAI 3F NEW MATERIALS CO L (CN) | 2007-01-10 | — | — | CN | disclosed |
| CN-1854181-A | Laminate hose made of fluorocopolymer | ASAHI GLASS CO LTD (JP) | 2006-11-01 | — | — | CN | disclosed |
| EP-1187798-B8 | PRODUCTION OF OPTICALLY ACTIVE ALPHA-HYDROXYACETALS | SOLVIAS AG (CH) | 2006-10-25 | — | — | EP | disclosed |
| US-20060235031-A1 | 6,6-Bicyclic ring substituted heterobicyclic protein kinase inhibitors | ACERTA PHARMA B.V. (NL) | 2006-10-19 | — | — | US | disclosed |
| CN-1837283-A | Resin composition for color filter protective film and color filter | NIPPON OILS & FATS CO LTD (JP) | 2006-09-27 | — | — | CN | disclosed |
| US-20060204703-A1 | Use of silane-functional polyvinyl alcohols in priming agents for separating papers and films | WACKER POLYMER SYSTEMS GMBH & CO. KG (DE) | 2006-09-14 | — | — | US | disclosed |
| CN-1274730-C | Fluorine copolymer | ASAHI GLASS CO LTD (JP) | 2006-09-13 | — | — | CN | disclosed |
| CN-1819996-A | Naphthylene derivatives as cytochrome P450 inhibitors | OSI PHARM INC (US) | 2006-08-16 | — | — | CN | disclosed |
| WO-2006083628-A2 | MEDICAL DEVICES HAVING POLYMERIC REGIONS WITH COPOLYMERS CONTAINING HYDROCARBON AND HETEROATOM-CONTAINING MONOMERIC SPECIES | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2006-08-10 | — | — | WO | disclosed |
| EP-1675860-A2 | IMIDAZO[1,5-A]PYRAZINE TYROSINE KINASE INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2006-07-05 | — | — | EP | disclosed |
| WO-2006062110-A1 | PIPERAZINE DERIVATIVE | BANYU PHARMACEUTICAL CO., LTD. (JP) | 2006-06-15 | — | — | WO | disclosed |
| EP-1187798-B1 | PRODUCTION OF OPTICALLY ACTIVE $g(a)-HYDROXYACETALS | SOLVIAS AG (CH) | 2006-06-14 | — | — | EP | disclosed |
| EP-1654236-A1 | NAPHTHYLENE DERIVATIVES AS CYTOCHROME P450 INHIBITORS | OSI Pharmaceuticals, Inc. (US) | 2006-05-10 | — | — | EP | disclosed |
| CN-1763060-A | Metallocene compound, indene compound and application thereof | BASELL POLYOLEFINE GMBH (DE) | 2006-04-26 | — | — | CN | disclosed |
| CN-1762957-A | 2,3-dihydro-1-indene compound and preparation method thereof | BASELL POLYOLEFINE GMBH (DE) | 2006-04-26 | — | — | CN | disclosed |
| US-20060084654-A1 | Imidazopyrazine tyrosine kinase inhibitors | ACERTA PHARMA B.V. (NL) | 2006-04-20 | — | — | US | disclosed |
| CN-1742064-A | Coating composition | DAIKIN IND LTD (JP) | 2006-03-01 | — | — | CN | disclosed |
| CN-1731994-A | Prophylactic and therapeutic agent for neuropathy | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 2006-02-08 | — | — | CN | disclosed |
| WO-2006012422-A1 | IMIDAZOPYRAZINE AS TYROSINE KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2006-02-02 | — | — | WO | disclosed |
| US-20060019957-A1 | Imidazotriazines as protein kinase inhibitors | OSI PHARMACEUTICALS, INC. | 2006-01-26 | — | — | US | disclosed |
| US-20060009645-A1 | Naphthylene derivatives as cytochrome P450 inhibitors | OSI PHARMACEUTICALS, INC. | 2006-01-12 | — | — | US | disclosed |
| US-20060004069-A1 | Agent for preventing or treating neuropathy | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2006-01-05 | — | — | US | disclosed |
| EP-1354883-B1 | Hydrogenation of prochiral ketones | SOLVIAS AG (CH) | 2005-12-28 | — | — | EP | disclosed |
| CN-1231431-C | Process for preparing substituted 2, 3-dihydro-1-indanones | TARGOR GMBH (DE) | 2005-12-14 | — | — | CN | disclosed |
| WO-2005097800-A1 | 6,6-BICYCLIC RING SUBSTITUTED HETEROBICYCLIC PROTEIN KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2005-10-20 | — | — | WO | disclosed |
| CN-1221505-C | Process for preparing alkanediol derivatives | IHARA CHEMICAL IND CO (JP) | 2005-10-05 | — | — | CN | disclosed |
| EP-1556032-A1 | AGENT FOR PREVENTING OR TREATING NEUROPATHY | Takeda Pharmaceutical Company Limited (JP) | 2005-07-27 | — | — | EP | disclosed |
| CN-1644353-A | Fluorine copolymer | ASAHI GLASS CO LTD (JP) | 2005-07-27 | — | — | CN | disclosed |
| CN-1629230-A | Soluble fluorine-containing paint resin and method for preparing same | SHANGHAI 3F NEW MATERIALS CO L (CN) | 2005-06-22 | — | — | CN | disclosed |
| US-20050090534-A1 | Azole compounds | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2005-04-28 | — | — | US | disclosed |
| WO-2005037836-A2 | IMIDAZO ‘1, 5 - A ! PYRAZINE TYROSINE KINASE INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2005-04-28 | — | — | WO | disclosed |
| WO-2005007631-A1 | NAPHTHYLENE DERIVATIVES AS CYTOCHROME P450 INHIBITORS | OSI PHARMACEUTICALS, INC. (US) | 2005-01-27 | — | — | WO | disclosed |
| US-20040254182-A1 | Enhanced propertied pharmaceuticals | ROHM AND HAAS COMPANY | 2004-12-16 | — | — | US | disclosed |
| EP-1486490-A1 | AZOLE COMPOUNDS | Takeda Chemical Industries, Ltd. (JP) | 2004-12-15 | — | — | EP | disclosed |
| CN-1172892-C | Stabilizing composition for O-and N-vinyl compounds and use of ammonium salts as stabilizers | �����ɷ� | 2004-10-27 | — | — | CN | disclosed |
| US-6794532-B2 | ENANTIOSELECTIVELY HYDROGENATING PROCHIRALEN KETONES TO (S)-ALCOHOLS USING PLATINUM CATALYSTS IN PRESENCE OF CINCHONINES OR QUINIDINES AS MODIFIERS, WHEREIN MODIFIERS USED ARE CINCHONINES UNSUBSTITUTED IN 3-POSITION | SOLVIAS AG (CH) | 2004-09-21 | — | — | US | disclosed |
| WO-2004039365-A1 | AGENT FOR PREVENTING OR TREATING NEUROPATHY | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-05-13 | — | — | WO | disclosed |
| CN-1477133-A | Fluorine copolymer | 旭硝子株式会社 | 2004-02-25 | — | — | CN | disclosed |
| US-6660890-B1 | Heterogeneous and enantioselective hydrogenation of prochiral alpha -ketoacetals with platinum as the catalyst and in the presence of a chiral aromatic nitrogen base | SOLVIAS AG (CH) | 2003-12-09 | — | — | US | disclosed |
| US-20030204112-A1 | Hydrogenation of prochiral ketones | SOLVIAS AG (CH) | 2003-10-30 | — | — | US | disclosed |
| EP-1354883-A1 | Hydrogenation of prochiral ketones | Solvias AG (CH) | 2003-10-22 | — | — | EP | disclosed |
| CN-1441790-A | Enhanced propertied pharmaceuticals | ROHM & HAAS (US) | 2003-09-10 | — | — | CN | disclosed |
| US-6617475-B2 | Prepared from prochiral alpha-ketoethers by heterogeneous hydrogenation using platinum catalysts in the presence of a chiral nitrogen base in high chemical and optical yields | SOLVIAS AG (CH) | 2003-09-09 | — | — | US | disclosed |
| US-20030109712-A1 | Preparation of optically active alpha-hydroxyethers | SOLVIAS AG (CH) | 2003-06-12 | — | — | US | disclosed |
| WO-2003035791-A1 | COMPOSITION FOR AVOIDING OR REDUCING THE BUILD-UP OF ICE AND SNOW, METHOD FOR PRODUCTION AND USE OF SAID COMPOSITION | BASF AKTIENGESELLSCHAFT (DE) | 2003-05-01 | — | — | WO | disclosed |
| EP-1291336-A2 | Preparation of optically active alpha-hydroxyethers | Solvias AG (CH) | 2003-03-12 | — | — | EP | disclosed |
| EP-1272463-A1 | ENHANCED PROPERTIED PHARMACEUTICALS | ROHM AND HAAS COMPANY (US) | 2003-01-08 | — | — | EP | disclosed |
| WO-2002079176-A1 | PROCESS FOR 2,4-DISUBSTITUTED-1,3,4-OXADIAZOLINE-5-THIONE AND 5-ONE COMPOUNDS | DOW AGROSCIENCES LLC (US) | 2002-10-10 | — | — | WO | disclosed |
| WO-2002072559-A1 | PROCESS TO INTERMEDIATES FOR BIOLOGICALLY ACTIVE COMPOUNDS | ROHM AND HAAS COMPANY (US) | 2002-09-19 | — | — | WO | disclosed |
| EP-1235893-A2 | ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-1235892-A1 | COMPOSITIONS INCLUDING ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-1235778-A2 | PROCESS FOR PREPARING ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-1235639-A1 | COMPOSITIONS INCLUDING ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL WETTING AGENTS | The Procter & Gamble Company (US) | 2002-09-04 | — | — | EP | disclosed |
| EP-0672746-B1 | Oxime ethers and perfume and flavouring compositions containing them | GIVAUDAN SA (CH) | 2002-05-29 | — | — | EP | disclosed |
| EP-0711760-B1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL IND LTD (JP) | 2002-05-15 | — | — | EP | disclosed |
| US-6376548-B1 | FUNGICIDES; HERBICIDES; INSECTICIDES | ROHM AND HAAS COMPANY | 2002-04-23 | — | — | US | disclosed |
| EP-1187798-A1 | PRODUCTION OF OPTICALLY ACTIVE $g(a)-HYDROXYACETALS | Solvias AG (CH) | 2002-03-20 | — | — | EP | disclosed |
| CN-1340040-A | Stabilizing composition for O-and N-vinyl compounds and use of ammonium salts as stabilizers | BASF AG (DE) | 2002-03-13 | — | — | CN | disclosed |
| CN-1336907-A | Process for the production of alkanediol derivatives | IHARA CHEMICAL IND CO (JP) | 2002-02-20 | — | — | CN | disclosed |
| US-20010039343-A1 | Process to intermediates for biologically active compounds | MULVIHILL MARK JOSEPH (US) | 2001-11-08 | — | — | US | disclosed |
| EP-1140865-A1 | TRIAZOLE SULFONES HAVING HERBIDICIDAL ACTIVITY | Monsanto Co. (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-0882720-B1 | METHODS FOR MODIFYING 1,3,5-TRIAZINE DERIVATIVES | NISSAN CHEMICAL IND LTD (JP) | 2001-08-22 | — | — | EP | disclosed |
| WO-2001056358-A2 | ENHANCED PROPERTIED PESTICIDES | ROHM AND HAAS COMPANY (US) | 2001-08-09 | — | — | WO | disclosed |
| WO-2001054481-A2 | ENHANCED PROPERTIED PHARMACEUTICALS | ROHM AND HAAS COMPANY (US) | 2001-08-02 | — | — | WO | disclosed |
| WO-2001055082-A2 | INTERMEDIATES FOR BIOLOGICALLY ACTIVE COMPOUNDS | ROHM AND HAAS COMPANY (US) | 2001-08-02 | — | — | WO | disclosed |
| WO-2001041912-A2 | ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |
| WO-2001041909-A1 | COMPOSITIONS INCLUDING ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL WETTING AGENTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |
| WO-2001042411-A1 | COMPOSITIONS INCLUDING ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |
| WO-2001041910-A2 | PROCESS FOR PREPARING ETHER-CAPPED POLY(OXYALKYLATED) ALCOHOL SURFACTANTS | THE PROCTER & GAMBLE COMPANY (US) | 2001-06-14 | — | — | WO | disclosed |
| CN-1288464-A | 4- (2-keto-1-benzimidazolinyl) piperidine compounds as ORL-1 receptor agonists | PFIZER PHARMA (US) | 2001-03-21 | — | — | CN | disclosed |
| CN-1061649-C | Method for modifying 1,3,5-triazine derivatives | NISSAN CHEMICAL IND LTD (JP) | 2001-02-07 | — | — | CN | disclosed |
| WO-2001000545-A1 | PRODUCTION OF OPTICALLY ACTIVE α-HYDROXYACETALS | SOLVIAS AG (CH) | 2001-01-04 | — | — | WO | disclosed |
| CN-1058963-C | Triazole derivative, insecticidal/acaricidal agent, and process for producing the same | KUMIAI CHEMICAL INDUSTRY CO (JP) | 2000-11-29 | — | — | CN | disclosed |
| US-6130332-A | USING A GROUP 8 METAL CATALYST AND ALDEHYDES OR KETONE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-10 | — | — | US | disclosed |
| US-6127538-A | HYDROXYALKYLATION OF A TRIAMINO TRIAZINE DERIVATIVE HAVING AT LEAST ONE REACTIVE NITROGEN BY REACTING WHILE HEATING WITH AN ALKANEDIOL OR ITS ADDUCT IN THE PRESENCE OF HYDROGEN AND A METAL CATALYST; BY-PRODUCT INHIBITION | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2000-10-03 | — | — | US | disclosed |
| WO-2000042028-A1 | TRIAZOLE SULFONES HAVING HERBICIDAL ACTIVITY | MONSANTO TECHNOLOGY LLC (US) | 2000-07-20 | — | — | WO | disclosed |
| CN-1254328-A | Process for preparing substituted 2, 3-dihydro-1-indanones | TARGOR GMBH (DE) | 2000-05-24 | — | — | CN | disclosed |
| CN-1048243-C | Alkylation method of triazine derivative | NISSAN CHEMICAL IND LTD (JP) | 2000-01-12 | — | — | CN | disclosed |
| US-5993909-A | COMPRISING EPOXY GROUP CONTAINING MODIFIED POLYESTER AND A COMPOUND CONTAINING FUNCTIONAL GROUPS PER MOLECULE; COATINGS, INKS, ADHESIVES | NOF CORPORATION (JP) | 1999-11-30 | — | — | US | disclosed |
| US-5962612-A | POWDER COATING | ASAHI GLASS COMPANY LTD. (JP) | 1999-10-05 | — | — | US | disclosed |
| CN-1206409-A | Method for modifying 1,3, 5-triazine derivative | NISSAN CHEMICAL IND LTD (JP) | 1999-01-27 | — | — | CN | disclosed |
| EP-0882720-A1 | METHODS FOR MODIFYING 1,3,5-TRIAZINE DERIVATIVES | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1998-12-09 | — | — | EP | disclosed |
| US-5792867-A | Method of alkylating of triazine derivatives | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1998-08-11 | — | — | US | disclosed |
| CN-1185164-A | Homopolymers and copolymers of cationically polymerizable monomers, and prepn. method therefor | GOODRICH CO B F (US) | 1998-06-17 | — | — | CN | disclosed |
| US-5700824-A | Triazole derivatives, insecticide, acaricide and methods thereof | KUMIAI CHEMICAL INDUSTRIAL CO. LTD. (JP) | 1997-12-23 | — | — | US | disclosed |
| CN-1147812-A | Alkylation method of triazine derivative | NISSAN CHEMICAL IND LTD (JP) | 1997-04-16 | — | — | CN | disclosed |
| US-5616594-A | Triazole derivatives, insecticide, acaricide and methods thereof | IHARA CHEMICAL INDUSTRY CO. LTD. (JP) | 1997-04-01 | — | — | US | disclosed |
| EP-0760369-A1 | PROCESS FOR ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1997-03-05 | — | — | EP | disclosed |
| US-5599937-A | Heteroaromatic quinuclidinenes, their use and preparation | PHARMACIA AB (SE) | 1997-02-04 | — | — | US | disclosed |
| EP-0572142-B1 | Novel 3,5-diphenyl substituted 1,2,4-triazoles and their use as insecticides and acaricides | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1996-07-31 | — | — | EP | disclosed |
| CN-1127506-A | Method of alkylating triazine derivative | NISSAN CHEMICAL IND LTD (JP) | 1996-07-24 | — | — | CN | disclosed |
| EP-0711760-A1 | METHOD OF ALKYLATING TRIAZINE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) | 1996-05-15 | — | — | EP | disclosed |
| EP-0672746-A1 | Oxime ethers and perfume and flavouring compositions containing them | GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) | 1995-09-20 | — | — | EP | disclosed |
| CN-1105179-A | Triazole derivative, insecticidal/acaricidal agent, and process for producing the same | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1995-07-12 | — | — | CN | disclosed |
| EP-0648752-A1 | TRIAZOLE DERIVATIVE, INSECTICIDAL/ACARICIDAL AGENT, AND PROCESS FOR PRODUCING THE SAME | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1995-04-19 | — | — | EP | disclosed |
| EP-0640082-A1 | HETEROAROMATIC QUINUCLIDINENES, THEIR USE AND PREPARATION | Pharmacia & Upjohn Aktiebolag (SE) | 1995-03-01 | — | — | EP | disclosed |
| US-5374682-A | Hard, acid resistant automobile topcoatings | NIPPON PAINT CO., LTD. (JP) | 1994-12-20 | — | — | US | disclosed |
| EP-0602242-A1 | BENZISOXAZOLE COMPOUND AND USE THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1994-06-22 | — | — | EP | disclosed |
| US-5318959-A | A new miticides diaryl alkyl 1,2,4-triazoles | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1994-06-07 | — | — | US | disclosed |
| EP-0594205-A1 | Curable composition for paint | KANEGAFUCHI KAGAKU KOGYO KABUSHIKI KAISHA (JP) | 1994-04-27 | — | — | EP | disclosed |
| US-5278148-A | Hypotensive agents | HOFFMANN-LA ROCHE INC. (US) | 1994-01-11 | — | — | US | disclosed |
| CN-1079221-A | New triazole derivative and sterilant and miticide | KUMIAI CHEMICAL INDUSTRY CO (JP) | 1993-12-08 | — | — | CN | disclosed |
| EP-0572142-A2 | Novel 3,5-diphenyl substituted 1,2,4-triazoles and their use as insecticides and acaricides | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 1993-12-01 | — | — | EP | disclosed |
| WO-1993023395-A1 | HETEROAROMATIC QUINUCLIDINENES, THEIR USE AND PREPARATION | KABI PHARMACIA AB (SE) | 1993-11-25 | — | — | WO | disclosed |
| US-5250517-A | Hypotensive and cardiotonic agents; cardiac insufficiency | HOFFMANN-LA ROCHE INC. (US) | 1993-10-05 | — | — | US | disclosed |
| US-5169915-A | Solvent solubility, compatibility with curing agents | DAIKIN INDUSTRIES, LTD. (JP) | 1992-12-08 | — | — | US | disclosed |
| US-5140011-A | Hypotensive agents | HOFFMANN-LA ROCHE, INC. (US) | 1992-08-18 | — | — | US | disclosed |
| EP-0433106-A1 | Curable fluorinated copolymers, their method of preparation and their use in laquers and paints | ELF ATOCHEM S.A. (FR) | 1991-06-19 | — | — | EP | disclosed |
| EP-0400290-A1 | 5-Amino-4-hydroxyvalerianic acid derivatives useful as intermediates in the preparation of renin inhibitors | CIBA-GEIGY AG (CH) | 1990-12-05 | — | — | EP | disclosed |
| EP-0391179-A2 | Peptide derivatives of amino acids having a renin-inhibiting effect | F. HOFFMANN-LA ROCHE AG (CH) | 1990-10-10 | — | — | EP | disclosed |
| EP-0391180-A2 | Peptide derivatives of amino acids having a renin-inhibiting effect | F. HOFFMANN-LA ROCHE AG (CH) | 1990-10-10 | — | — | EP | disclosed |
| EP-0389898-A2 | Peptide derivatives of amino acids having a renin-inhibiting effect | F. HOFFMANN-LA ROCHE AG (CH) | 1990-10-03 | — | — | EP | disclosed |
| US-4952690-A | 6-substituted thia-aza compounds | CIBA-GEIGY CORPORATION (US) | 1990-08-28 | — | — | US | disclosed |
| EP-0166692-B1 | SUBSTITUTED AZABICYCLOHEPTANES, THEIR USE, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND PROCESS FOR THE PREPARATION OF THE COMPOUNDS | CIBA-GEIGY AG (CH) | 1990-07-11 | — | — | EP | disclosed |
| US-4931591-A | Novel 5-amino-4-hydroxyvaleryl derivatives | CIBA-GEIGY CORPORATION (US) | 1990-06-05 | — | — | US | disclosed |
| EP-0363900-A2 | Carriers for developing electrostatic images | DAIKIN INDUSTRIES, LIMITED (JP) | 1990-04-18 | — | — | EP | disclosed |
| US-4876251-A | ANTIBIOTICS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-10-24 | — | — | US | disclosed |
| US-4863903-A | RENIN ENZYME INHIBITORS, HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1989-09-05 | — | — | US | disclosed |
| US-4857660-A | ENZYME INHIBITORS, ANTICANCER AGENTS | CIBA-GEIGY CORPORATION (US) | 1989-08-15 | — | — | US | disclosed |
| US-4839379-A | AROMATASE INHIBITORS | CIBA-GEIGY CORPORATION (US) | 1989-06-13 | — | — | US | disclosed |
| EP-0310918-A2 | Peptide-like amino-acid derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1989-04-12 | — | — | EP | disclosed |
| EP-0114033-B1 | SUBSTITUTED AZABICYCLOALKANES, THEIR USE, PHARMACEUTICAL PREPARATIONS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THESE COMPOUNDS | CIBA-GEIGY AG (CH) | 1988-10-12 | — | — | EP | disclosed |
| US-4764640-A | AROMATOSE INHIBITOR | CIBA-GEIGY CORPORATION (US) | 1988-08-16 | — | — | US | disclosed |
| US-4727060-A | HYPOTENSIVE AGENTS | CIBA-GEIGY CORPORATION (US) | 1988-02-23 | — | — | US | disclosed |
| US-4719288-A | HYPOTENSIVE | CIBA-GEIGY CORPORATION (US) | 1988-01-12 | — | — | US | disclosed |
| EP-0249909-A1 | Tricyclic penam compounds, their production and their use | Takeda Chemical Industries, Ltd. (JP) | 1987-12-23 | — | — | EP | disclosed |
| US-4692442-A | ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1987-09-08 | — | — | US | disclosed |
| US-4683303-A | Reduction process for the preparation of 4-unsubstituted azetidin-2-ones | PFAENDLER HANS R (DE) | 1987-07-28 | — | — | US | disclosed |
| US-4677129-A | Substituted-3-azabicyclo[3.1.1]heptane-2,4-diones useful for treating hormone-dependent diseases | CIBA-GEIGY CORPORATION (US) | 1987-06-30 | — | — | US | disclosed |
| EP-0111711-B1 | HETEROCYCLICALLY SUBSTITUTED HYDROXYALKYL-AZOLYL DERIVATIVES | BAYER AG (DE) | 1987-03-18 | — | — | EP | disclosed |
| US-4639462-A | Heterocyclo-hydroxyalkyl-azolyl derivatives and use as fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 1987-01-27 | — | — | US | disclosed |
| US-4632932-A | TRIAZOLYL-DIOXOLANYL OR DIOXANYL COMPOUNDS | BAYER AKTIENGESELLSCHAFT (DE) | 1986-12-30 | — | — | US | disclosed |
| EP-0111146-B1 | ANTI-MYCOTIC HYDROXYALKYL-AZOLYL DERIVATIVES | BAYER AG (DE) | 1986-12-30 | — | — | EP | disclosed |
| US-4623649-A | PSYCHOPHARMACEUTICALS | SCHERING AKTIENGESELLSCHAFT (DE) | 1986-11-18 | — | — | US | disclosed |
| US-4613676-A | PEPTIDES | CIBA-GEIGY CORPORATION (US) | 1986-09-23 | — | — | US | disclosed |
| EP-0193642-A2 | Heterocyclically substituted hydroxyalkyl-azolyl derivatives | BAYER AG (DE) | 1986-09-10 | — | — | EP | disclosed |
| EP-0184550-A2 | 5-Amino-4-hydroxy valeryl amide derivatives | CIBA-GEIGY AG (CH) | 1986-06-11 | — | — | EP | disclosed |
| EP-0042026-B1 | 3,4-DISUBSTITUTED AZETIDIN-2-ON COMPOUNDS AND PROCESS FOR THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1986-01-08 | — | — | EP | disclosed |
| EP-0166692-A2 | Substituted azabicycloheptanes, their use, pharmaceutical compositions comprising them and process for the preparation of the compounds | CIBA-GEIGY AG (CH) | 1986-01-02 | — | — | EP | disclosed |
| EP-0144290-A2 | Substituted ethylenediamine derivatives | CIBA-GEIGY AG (CH) | 1985-06-12 | — | — | EP | disclosed |
| EP-0143746-A2 | 5-Amino 4-hydroxy-valeryl-substituted derivatives | CIBA-GEIGY AG (CH) | 1985-06-05 | — | — | EP | disclosed |
| EP-0137390-A1 | Substituted beta-carbolines, process for their preparation and their use as medicaments | SCHERING AKTIENGESELLSCHAFT (DE) | 1985-04-17 | — | — | EP | disclosed |
| EP-0023887-B1 | 3-SUBSTITUTED BICYCLIC AZETIDINONE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND INTERMEDIATES AS WELL AS THEIR PREPARATION | CIBA-GEIGY AG (CH) | 1984-11-07 | — | — | EP | disclosed |
| EP-0114033-A1 | Substituted azabicycloalkanes, their use, pharmaceutical preparations containing these compounds and process for preparing these compounds | CIBA-GEIGY AG (CH) | 1984-07-25 | — | — | EP | disclosed |
| EP-0111711-A2 | Heterocyclically substituted hydroxyalkyl-azolyl derivatives | BAYER AG (DE) | 1984-06-27 | — | — | EP | disclosed |
| EP-0111146-A2 | Anti-mycotic hydroxyalkyl-azolyl derivatives | BAYER AG (DE) | 1984-06-20 | — | — | EP | disclosed |
| US-4436661-A | INTERMEDIATES FOR PENICILLIN ANTIBIOTICS | CIBA-GEIGY CORPORATION (US) | 1984-03-13 | — | — | US | disclosed |
| US-4431588-A | PENACILLINS | CIBA-GEIGY CORPORATION (US) | 1984-02-14 | — | — | US | disclosed |
| EP-0092830-A2 | Cephalosporin derivatives, process for their preparation, pharmaceutical compositions containing them and their application | CIBA-GEIGY AG (CH) | 1983-11-02 | — | — | EP | disclosed |
| JP-S58133874-A | UNDERWATER CORROSION PREVENTIVE COATING METHOD | ASAHI GLASS CO LTD | 1983-08-09 | — | — | JP | disclosed |
| EP-0003960-B1 | 6-SUBSTITUTED THIA-AZA-COMPOUNDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | CIBA-GEIGY AG (CH) | 1983-06-29 | — | — | EP | disclosed |
| JP-S57202369-A | LIQUID CRYSTAL MATERIAL AND LIQUID CRYSTAL DISPLAY ELEMENT | NEC CORP | 1982-12-11 | — | — | JP | disclosed |
| EP-0042026-A1 | 3,4-Disubstituted azetidin-2-on compounds and process for their preparation | CIBA-GEIGY AG (CH) | 1981-12-23 | — | — | EP | disclosed |
| US-4297300-A | Novel α-haloalkylcarbamic acid halides, and a process for the preparation of α-haloalkylcarbamic acid halides | BASF AKTIENGESELLSCHAFT (DE) | 1981-10-27 | — | — | US | disclosed |
| EP-0023887-A2 | 3-Substituted bicyclic azetidinone derivatives, process for their preparation, and intermediates as well as their preparation | CIBA-GEIGY AG (CH) | 1981-02-11 | — | — | EP | disclosed |
| US-4224297-A | HEATING IN AIR OR NITROGEN | WACKER-CHEMIE GMBH (DE) | 1980-09-23 | — | — | US | disclosed |
| EP-0007498-A1 | Alpha-halogeno-alkyl carbamyl halides and a process for preparing them | BASF Aktiengesellschaft (DE) | 1980-02-06 | — | — | EP | disclosed |
| EP-0003960-A1 | 6-Substituted thia-aza-compounds, their preparation and pharmaceutical compositions containing them | CIBA-GEIGY AG (CH) | 1979-09-19 | — | — | EP | disclosed |
| US-3997708-A | ADDITION | PHILLIPS PETROLEUM COMPANY (US) | 1976-12-14 | — | — | US | disclosed |
| US-3997708-A | ADDITION | PHILLIPS PETROLEUM COMPANY (US) | 1976-12-14 | — | — | US | disclosed |